<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6566829</article-id><article-id pub-id-type="doi">10.3390/nu11051134</article-id><article-id pub-id-type="publisher-id">nutrients-11-01134</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Can Gut Microbiota Composition Predict Response to Dietary Treatments?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Biesiekierski</surname><given-names>Jessica R</given-names></name><xref ref-type="aff" rid="af1-nutrients-11-01134">1</xref><xref rid="c1-nutrients-11-01134" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3847-8136</contrib-id><name><surname>Jalanka</surname><given-names>Jonna</given-names></name><xref ref-type="aff" rid="af2-nutrients-11-01134">2</xref><xref ref-type="aff" rid="af3-nutrients-11-01134">3</xref></contrib><contrib contrib-type="author"><name><surname>Staudacher</surname><given-names>Heidi M</given-names></name><xref ref-type="aff" rid="af4-nutrients-11-01134">4</xref></contrib></contrib-group><aff id="af1-nutrients-11-01134"><label>1</label>Department of Dietetics, Nutrition &#x00026; Sport, School of Allied Health Human Services &#x00026; Sport, La Trobe University, 3086 Melbourne, Australia</aff><aff id="af2-nutrients-11-01134"><label>2</label>Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 HY Helsinki, Finland; <email>jonna.jalanka@helsinki.fi</email></aff><aff id="af3-nutrients-11-01134"><label>3</label>Nottingham Digestive Diseases Centre and NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals NHS Trust, the University of Nottingham, Nottingham NG7 2RD, UK</aff><aff id="af4-nutrients-11-01134"><label>4</label>Food and Mood Centre, IMPACT SRC, Deakin University, Geelong, VIC 3216, Australia; <email>heidi.staudacher@deakin.edu.au</email></aff><author-notes><corresp id="c1-nutrients-11-01134"><label>*</label>Correspondence: <email>j.biesiekierski@latrobe.edu.au</email>; Tel.: +61-3-9479-5601</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2019</year></pub-date><volume>11</volume><issue>5</issue><elocation-id>1134</elocation-id><history><date date-type="received"><day>18</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>20</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Dietary intervention is a challenge in clinical practice because of inter-individual variability in clinical response. Gut microbiota is mechanistically relevant for a number of disease states and consequently has been incorporated as a key variable in personalised nutrition models within the research context. This paper aims to review the evidence related to the predictive capacity of baseline microbiota for clinical response to dietary intervention in two specific health conditions, namely, obesity and irritable bowel syndrome (IBS). Clinical trials and larger predictive modelling studies were identified and critically evaluated. The findings reveal inconsistent evidence to support baseline microbiota as an accurate predictor of weight loss or glycaemic response in obesity, or as a predictor of symptom improvement in irritable bowel syndrome, in dietary intervention trials. Despite advancement in quantification methodologies, research in this area remains challenging and larger scale studies are needed until personalised nutrition is realistically achievable and can be translated to clinical practice.</p></abstract><kwd-group><kwd>personalised nutrition</kwd><kwd>microbiota</kwd><kwd>dietary intervention</kwd><kwd>obesity</kwd><kwd>irritable bowel syndrome</kwd><kwd>gastrointestinal symptoms</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-11-01134"><title>1. Introduction</title><p>Diet is a modifiable risk factor for many non-communicable diseases and there is a high level of evidence supporting the efficacy of dietary interventions for both influencing disease risk and improving disease outcomes. For example, dietary intervention can reduce cardiovascular disease risk by 60% [<xref rid="B1-nutrients-11-01134" ref-type="bibr">1</xref>] and can successfully reduce gastrointestinal (GI) symptoms in at least 50% of patients with irritable bowel syndrome (IBS) [<xref rid="B2-nutrients-11-01134" ref-type="bibr">2</xref>]. However, individual variability in response to treatment is increasingly recognised, and this is reflected in the highly variable response rates in clinical trials of dietary interventions, particularly in obesity [<xref rid="B3-nutrients-11-01134" ref-type="bibr">3</xref>], cardiovascular disease [<xref rid="B4-nutrients-11-01134" ref-type="bibr">4</xref>] and IBS [<xref rid="B2-nutrients-11-01134" ref-type="bibr">2</xref>].</p><p>Personalised nutrition essentially enables the tailoring of dietary advice to the individual level through the incorporation of data related to specific biological pathways driving that individual&#x02019;s health or disease status, ultimately optimising the effectiveness of the advice. A comprehensive understanding of clinical conditions and underlying disease mechanisms is often required, including the genetic variants of the patient and the extent to which these variants interact with diet to affect disease risk and treatment in diverse populations.</p><p>Personalised nutrition models integrate a variety of host-specific variables including current diet, biological or phenotypical characteristics of the individual (age, stage of life, gender, body mass index (BMI), disease or health status) and genotypic characteristics. An understanding of epigenetics (regulation of gene expression) is also often included. Models will vary with the clinical condition and its underlying mechanisms, and with the research hypothesis, where different combinations of characteristics are possible. Most evidence supporting personalised nutrition has come from observational studies with disease risk factors as outcomes (e.g., postprandial glucose response). However, there are some trials using clinical endpoints that have incorporated participant information to test prediction of responses [<xref rid="B5-nutrients-11-01134" ref-type="bibr">5</xref>] and large-scale studies collecting multi-dimensional data to predict response to acute diet challenges [<xref rid="B6-nutrients-11-01134" ref-type="bibr">6</xref>].</p><p>Gut microbiota is one variable shown to be mechanistically relevant for a number of disease states and therefore has a potential role in the development of personalised dietary advice. Microbiota has a profound impact on our health, and alterations to its composition and its dysfunction have been associated with several chronic diseases [<xref rid="B7-nutrients-11-01134" ref-type="bibr">7</xref>]. Despite the lack of a clear definition of a &#x0201c;healthy microbiota&#x0201d;, its general hallmarks include its resistance to compositional change and its responsiveness to environmental challenges [<xref rid="B8-nutrients-11-01134" ref-type="bibr">8</xref>]. This allows continuous operation of essential metabolic and immune functions including host nutrient metabolism, maintenance of structural integrity of the gut mucosal barrier, immunomodulation and protection against pathogens.</p><p>Diet is well known as one of the major drivers of microbiota composition [<xref rid="B9-nutrients-11-01134" ref-type="bibr">9</xref>] and conversely, the microbiota response to dietary intervention varies between individuals [<xref rid="B10-nutrients-11-01134" ref-type="bibr">10</xref>]. In the last decade, efforts have been directed to beginning to understand how biological response may be influenced by the baseline microbiota [<xref rid="B11-nutrients-11-01134" ref-type="bibr">11</xref>]. Much of the research investigating the predictive capacity of baseline microbiota for clinical response to dietary intervention has been reported in two specific health conditions, namely, obesity and IBS.</p><sec id="sec1dot1-nutrients-11-01134"><title>1.1. Clinical Condition 1: Obesity</title><p>Overweight and obesity rates continue to rise worldwide. In 2013, among adults (age &#x02265;20 years), 37% of men and 30% of women were considered overweight (BMI 25&#x02013;29.9) or obese (BMI &#x02265;30) [<xref rid="B12-nutrients-11-01134" ref-type="bibr">12</xref>]. Obesity is associated with numerous chronic diseases and increases the risk for type 2 diabetes, metabolic disorder and cancer [<xref rid="B13-nutrients-11-01134" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-11-01134" ref-type="bibr">14</xref>]. The pathogenesis of obesity is complex, with environmental, sociocultural, behavioural, physiological, genetic and epigenetic factors known to be contributors. Treatment often requires significant behaviour modification including dietary change and physical activity. Common dietary approaches include a low-fat diet, a high-protein diet or the DASH (Dietary Approaches to Stop Hypertension) diet [<xref rid="B15-nutrients-11-01134" ref-type="bibr">15</xref>,<xref rid="B16-nutrients-11-01134" ref-type="bibr">16</xref>]. Pharmacotherapy, medical devices and bariatric surgery are other treatment options for patients requiring additional intervention. Given the multifaceted nature of obesity, there is no single nor simple treatment solution, and therefore novel, and most likely personalised, interventions may be necessary for effective treatment.</p></sec><sec id="sec1dot2-nutrients-11-01134"><title>1.2. Clinical Condition 2: Irritable Bowel Syndrome</title><p>Irritable bowel syndrome (IBS), a chronic functional bowel disorder characterised by abdominal pain and altered bowel habit [<xref rid="B17-nutrients-11-01134" ref-type="bibr">17</xref>], affects 11% of individuals globally [<xref rid="B18-nutrients-11-01134" ref-type="bibr">18</xref>]. Positive diagnosis is based on the symptom profile meeting Rome IV criteria, and patients are classified into one of four IBS subtypes (diarrhoea-predominant, constipation-predominant, mixed and unsubtyped) [<xref rid="B17-nutrients-11-01134" ref-type="bibr">17</xref>]. The pathophysiology of IBS is not completely elucidated. Most factors proposed are embodied with the concept of a disturbed bidirectional brain&#x02013;gut axis, including alterations in the central nervous system (e.g., high prevalence of anxiety and depression), visceral hypersensitivity, increased gut epithelial permeability, low grade inflammation and an altered microbiome.</p><p>Lifestyle advice, including healthy diet and exercise, is usually considered as first line therapy, followed by symptom-directed pharmacotherapies (anti-spasmodics, laxatives, pro-secretory agents) which have varying efficacy and safety profile [<xref rid="B19-nutrients-11-01134" ref-type="bibr">19</xref>]. The low FODMAP diet, an approach restricting the intake of specific fermentable carbohydrates (i.e., oligo-, di-, mono-saccharides and polyols) is a second-line dietary intervention [<xref rid="B20-nutrients-11-01134" ref-type="bibr">20</xref>] and, although successful in inducing global symptom response in many, is often not effective for up to 50% of patients [<xref rid="B2-nutrients-11-01134" ref-type="bibr">2</xref>].</p></sec><sec id="sec1dot3-nutrients-11-01134"><title>1.3. Purpose of Review</title><p>Recent research suggests that dietary advice could be revolutionised towards a more personalised approach for a spectrum of disease states. Accurate prediction of clinical response, such as weight loss in obesity or symptom improvement in IBS, may not only improve short-term clinical response but also long-term treatment efficacy and overall health outcomes in response to dietary intervention. This paper aims to review the current state of evidence related to how knowledge of gut microbiota may facilitate personalised dietary treatments in obesity and in IBS, with a focus on human dietary intervention trials. In addition, the article aims to identify the knowledge gaps and address the implications of research to date. Studies were selected for inclusion if they assessed baseline microbiota composition as a prediction tool for the clinical response after dietary intervention in human cohorts with IBS and obesity. Can gut microbiota composition predict response to dietary treatments?</p></sec><sec id="sec1dot4-nutrients-11-01134"><title>1.4. Role of Intestinal Microbiota in Obesity</title><p>Several lines of evidence support a role for microbiota in the pathophysiology of obesity. The obese mouse model is characterised by a 50% decrease in <italic>Bacteroidetes</italic> abundance, an increase in <italic>Firmicutes</italic> [<xref rid="B21-nutrients-11-01134" ref-type="bibr">21</xref>] and a lower abundance of <italic>Akkermansia muciniphila</italic> [<xref rid="B22-nutrients-11-01134" ref-type="bibr">22</xref>] compared with lean mice. Clinical research in humans supports this, with evidence of fewer <italic>Bacteroides</italic> and more <italic>Firmicutes</italic> [<xref rid="B21-nutrients-11-01134" ref-type="bibr">21</xref>], as well as a lower abundance of <italic>Bifidobacteria</italic> [<xref rid="B23-nutrients-11-01134" ref-type="bibr">23</xref>] compared with lean controls. Obesity is also associated with a lower bacterial richness (where richness is defined as the number of different species in an ecosystem) and those with a lower bacterial richness gain more weight over time [<xref rid="B24-nutrients-11-01134" ref-type="bibr">24</xref>]. Efficacy of probiotics [<xref rid="B25-nutrients-11-01134" ref-type="bibr">25</xref>] and faecal microbiota transplantation (FMT) [<xref rid="B26-nutrients-11-01134" ref-type="bibr">26</xref>] (via colonisation with &#x0201c;lean microbiota&#x0201d;) to induce weight loss in obese individuals implies that attempts at &#x0201c;correcting&#x0201d; the microbial equilibrium can influence body weight and adiposity in obesity.</p><p>Although the underlying mechanisms by which gut microbiota contributes to obesity are not fully understood, evidence suggests contributing pathways include activity of the fermentation by-product short-chain fatty acids (SCFAs) in regulating gut hormones and influencing energy harvest [<xref rid="B27-nutrients-11-01134" ref-type="bibr">27</xref>]. Gut microbiota may also suppress the production of fasting-induced adipose factors [<xref rid="B28-nutrients-11-01134" ref-type="bibr">28</xref>] and be linked to inflammatory responses [<xref rid="B29-nutrients-11-01134" ref-type="bibr">29</xref>], regulation of lipogenesis pathways of triglyceride synthesis [<xref rid="B30-nutrients-11-01134" ref-type="bibr">30</xref>] and impaired innate immune interactions [<xref rid="B31-nutrients-11-01134" ref-type="bibr">31</xref>].</p></sec><sec id="sec1dot5-nutrients-11-01134"><title>1.5. Impact of Dietary Treatment on the Microbiome in Obesity</title><p>Energy restriction is the staple dietary intervention in obesity. When obese humans are assigned to either a fat-restricted or carbohydrate-restricted diet, the resulting increase in abundance of <italic>Bacteroidetes</italic> correlates with percentage loss of body weight [<xref rid="B21-nutrients-11-01134" ref-type="bibr">21</xref>]. Others demonstrate that three months of a formula-based very low-calorie diet (800 kcal/day) in 18 obese adults led to 21 kg average weight loss with concomitant changes in microbiota and bacterial metabolism [<xref rid="B32-nutrients-11-01134" ref-type="bibr">32</xref>]. The indicative taxa for the microbial diversity change involved the increase in <italic>Acinetobacter.</italic> Furthermore, a six-week energy-restricted high-protein diet in 38 obese adults improved low gene richness (i.e., number of detected bacterial genes) and increased the abundance of most gene clusters [<xref rid="B33-nutrients-11-01134" ref-type="bibr">33</xref>]. Another study assessed the impact of a Mediterranean diet compared with a low-fat diet in 20 obese men. There were no significant differences in the metabolic variables measured (weight change was not reported) between the diets after one year of dietary intervention. However, the low-fat diet group demonstrated an increased relative abundance of <italic>Prevotella</italic> and decreased <italic>Roseburia</italic> genera from baseline, whereas the Mediterranean diet led to the reverse, a decreased abundance of <italic>Prevotella</italic> and increased abundances of the <italic>Roseburia</italic> and <italic>Oscillospira</italic> genera from baseline [<xref rid="B34-nutrients-11-01134" ref-type="bibr">34</xref>]. These diets led to differential alterations in gut microbiota due to changes in food groups.</p><p>In addition to energy restriction, dietary interventions designed to target gut microbiota have used a range of potential modulators and have assessed various obesity risk factors. For example, one prebiotic supplementation study showed that a 16-week intervention of oligofructose-enriched inulin in overweight or obese children (7&#x02013;12 years) led to a greater abundance of <italic>Bifidobacteria</italic> compared with controls who received maltodextrin [<xref rid="B35-nutrients-11-01134" ref-type="bibr">35</xref>]. Many other within-group changes were observed for microbiota, but importantly, changes in gut microbial abundance coincided with beneficial changes in body composition and biological parameters of interleukin-6 and serum triglycerides compared with controls. Others have studied the effect of prebiotics through food or whole diet interventions. One uncontrolled trial delivered a diet rich in non-digestible carbohydrates (based on whole grains, traditional Chinese medicinal foods and prebiotics) via hospitalised intervention in 21 morbidly obese children (3&#x02013;16 years) for 30 days [<xref rid="B36-nutrients-11-01134" ref-type="bibr">36</xref>]. Microbiota composition, which had been enriched with potentially pathogenic bacteria at baseline, was much higher post-intervention in beneficial groups of bacteria, such as <italic>Bifidobacterium</italic> spp. Structural changes at the individual bacterial genome level were also significantly associated with improvements in host metabolic health (e.g., serum antigen load, alleviation of inflammation) alongside the 9.5% loss of initial bodyweight [<xref rid="B36-nutrients-11-01134" ref-type="bibr">36</xref>].</p></sec><sec id="sec1dot6-nutrients-11-01134"><title>1.6. Microbiome as a Predictor for Dietary Treatment Response in Obesity</title><p>In the last five years, there have been four relatively small dietary trials that assessed the association of baseline microbiota with either weight response in obese cohorts or the response of postprandial hyperglycaemia in healthy individuals, an independent risk factor for obesity. Furthermore, there have been two studies that used microbiota as a prediction tool to model weight response in obesity cohorts and two to predict glycaemic response in healthy individuals (<xref rid="nutrients-11-01134-t001" ref-type="table">Table 1</xref>).</p><p>First, a summary of the studies assessing weight response in obesity is presented. Two unrandomised trials have demonstrated the utility of baseline microbiota in predicting bodyweight response to dietary intervention. One showed that a higher gene richness at baseline was associated with a greater reduction in adipose tissue and systemic inflammation after a six-week energy-restricted high-protein diet (<italic>n</italic> = 38) [<xref rid="B33-nutrients-11-01134" ref-type="bibr">33</xref>]. The other reported that higher baseline abundance of <italic>Akkermansia muciniphila</italic> was associated with greater improvement in insulin sensitivity and body fat distribution after a six-week energy-restricted diet (<italic>n</italic> = 49) [<xref rid="B37-nutrients-11-01134" ref-type="bibr">37</xref>]. The first of two modelling studies implemented a six-week energy-restricted, high-protein diet followed by a six-week period of weight maintenance in obese or overweight individuals (<italic>n</italic> = 50) [<xref rid="B38-nutrients-11-01134" ref-type="bibr">38</xref>]. A combination of biological, gut microbiota and environmental factors were used to predict individual weight loss trajectory using a graphical Bayesian network framework. Those who lost the least weight and regained the most were characterised by higher abundances of <italic>Lactobacillus</italic>, <italic>Leuconostoc and Pediococcus</italic> genera. The overall microbiota composition at baseline was not identified by the framework as a predictor for weight loss. In another modelling study, the likelihood of weight loss in 78 obese adults undertaking high-fibre dietary interventions was related to the abundance of <italic>Firmicutes</italic> at baseline [<xref rid="B39-nutrients-11-01134" ref-type="bibr">39</xref>].</p><p>Key studies in the personalised nutrition field have investigated postprandial glycaemic responses (PPGR) to dietary intervention. One crossover randomised clinical trial (RCT) randomised 39 healthy participants to a three-day intervention of barley kernel-based bread or white wheat flour bread (100 g starch/day). The 10 participants demonstrating the most pronounced improvement in glucose and insulin response after a standardised breakfast following the barley kernel-based bread intervention were classified as responders. Responders were characterised by a higher <italic>Prevotella/Bacteroides</italic> ratio, higher relative abundance of <italic>Dorea</italic> and greater microbial potential to ferment complex oligosaccharides at baseline compared with non-responders [<xref rid="B40-nutrients-11-01134" ref-type="bibr">40</xref>]. Also implementing a bread intervention, a second RCT provided 20 healthy participants with three portions of 145 g sourdough-leavened whole-grain bread or 110 g white bread per day for one week. The interpersonal variability in glycaemic response to the different bread types could be reliably predicted with baseline microbiome data (accuracy ROC curve of 0.83) [<xref rid="B41-nutrients-11-01134" ref-type="bibr">41</xref>].</p><p>The most impressive study that has investigated predictors of biological responses to diet to date is a large predictive modelling study. Participants&#x02019; (<italic>n</italic> = 800) blood glucose was continuously monitored for one week whilst they recorded daily activities and dietary intake [<xref rid="B6-nutrients-11-01134" ref-type="bibr">6</xref>]. The PPGR to the first meal of every day, which was one of four different standardised meals (equivalent to 50 g carbohydrate), was a key component of a large dataset of clinical, anthropometric, dietary and biological information. PPGR variability was associated with a variety of clinical factors (HbA1c%, BMI, systolic blood pressure and alanine aminotransferase (ALT) activity). However, intriguingly, Proteobacteria and Enterobacteriaceae were positively associated with some of the PPGR to the standardised meal; associations with glycaemic response were also evident for certain microbial pathways at the functional level. From these data, a prediction model using thousands of decision trees based on 137 features representing meal content, daily activity, blood parameters and microbiome features was then validated in a separate 100-person cohort [<xref rid="B6-nutrients-11-01134" ref-type="bibr">6</xref>]. Similarly, others have used six-day PPGR data in 327 healthy participants to demonstrate that baseline microbiome combined with other physiological characteristics is highly predictive of postprandial responses. This was more predictive than standard clinical approaches that incorporate calorie or carbohydrate content alone [<xref rid="B42-nutrients-11-01134" ref-type="bibr">42</xref>].</p><p>Together, the findings from the obesity cohorts and glycaemic response studies highlight that microbiota composition and abundance of specific taxa present an exciting opportunity to enable predicting responsiveness to diet. However, challenges in interpreting the evidence exist, including the heterogeneity of studies, such as the length of dietary challenge (three to six weeks in obesity, three days to one week in PPGR), the type and intensity of intervention (level of caloric restriction, types of carbohydrate) and the number of taxa analysed. Most studies defined their subject cohort, including presence of comorbidity and medication use; however, many did not report on other external factors that could influence microbiota composition (e.g., probiotics), which may have contributed to the heterogeneity of findings.</p></sec><sec id="sec1dot7-nutrients-11-01134"><title>1.7. Role of Intestinal Microbiota in IBS</title><p>Evidence for microbiota in the development and/or as a driving force of symptom severity in IBS has been accumulating for some 35 years. The line of evidence that is most well supported in the literature is the observation that the faecal microbiota composition of patients differs from that of healthy controls, although there is little consistency in findings across studies [<xref rid="B43-nutrients-11-01134" ref-type="bibr">43</xref>,<xref rid="B44-nutrients-11-01134" ref-type="bibr">44</xref>]. Reported differences include a higher <italic>Firmicutes/Bacteroidetes</italic> ratio [<xref rid="B45-nutrients-11-01134" ref-type="bibr">45</xref>,<xref rid="B46-nutrients-11-01134" ref-type="bibr">46</xref>,<xref rid="B47-nutrients-11-01134" ref-type="bibr">47</xref>,<xref rid="B48-nutrients-11-01134" ref-type="bibr">48</xref>,<xref rid="B49-nutrients-11-01134" ref-type="bibr">49</xref>], a lower <italic>Bifidobacteria</italic> abundance [<xref rid="B48-nutrients-11-01134" ref-type="bibr">48</xref>,<xref rid="B50-nutrients-11-01134" ref-type="bibr">50</xref>,<xref rid="B51-nutrients-11-01134" ref-type="bibr">51</xref>,<xref rid="B52-nutrients-11-01134" ref-type="bibr">52</xref>,<xref rid="B53-nutrients-11-01134" ref-type="bibr">53</xref>,<xref rid="B54-nutrients-11-01134" ref-type="bibr">54</xref>,<xref rid="B55-nutrients-11-01134" ref-type="bibr">55</xref>] and instability in response to dietary change [<xref rid="B56-nutrients-11-01134" ref-type="bibr">56</xref>] in IBS compared with healthy controls. Differences have not been limited to the luminal compartment; colonic mucosal microbial composition also deviates from healthy controls [<xref rid="B46-nutrients-11-01134" ref-type="bibr">46</xref>,<xref rid="B51-nutrients-11-01134" ref-type="bibr">51</xref>,<xref rid="B57-nutrients-11-01134" ref-type="bibr">57</xref>]. Distinct microbial profiles associated with severity of gut symptoms [<xref rid="B47-nutrients-11-01134" ref-type="bibr">47</xref>,<xref rid="B48-nutrients-11-01134" ref-type="bibr">48</xref>,<xref rid="B49-nutrients-11-01134" ref-type="bibr">49</xref>,<xref rid="B57-nutrients-11-01134" ref-type="bibr">57</xref>,<xref rid="B58-nutrients-11-01134" ref-type="bibr">58</xref>] or presence of psychological morbidity [<xref rid="B47-nutrients-11-01134" ref-type="bibr">47</xref>,<xref rid="B57-nutrients-11-01134" ref-type="bibr">57</xref>,<xref rid="B58-nutrients-11-01134" ref-type="bibr">58</xref>,<xref rid="B59-nutrients-11-01134" ref-type="bibr">59</xref>] support a potential role for microbiota in perpetuating symptoms. Although one of the most recent investigations of microbiota in IBS identified a distinct faecal and mucosal signature associated with categories of symptom severity in IBS [<xref rid="B49-nutrients-11-01134" ref-type="bibr">49</xref>], a unique and consistent microbial signature differentiating IBS from non-IBS has not been identified.</p><p>A number of other lines of evidence supporting the important role of microbiota in the pathophysiology of IBS come from animal models. The presence of transplanted microbiota from individuals with IBS in germ-free mice leads to the transfer of the disease state, including altered microbiota composition, visceral hypersensitivity, altered transit, immune activation and behavioural manifestations of the condition [<xref rid="B60-nutrients-11-01134" ref-type="bibr">60</xref>,<xref rid="B61-nutrients-11-01134" ref-type="bibr">61</xref>]. Other animal data suggest microbial metabolites, such as SCFAs, induce visceral hypersensitivity, a key feature of IBS [<xref rid="B62-nutrients-11-01134" ref-type="bibr">62</xref>]. In humans, additional support for the involvement of microbiota in IBS aetiology is the presence of systemic and mucosal immune activation, with the altered gut microbiota a potential key driver of this dysregulation [<xref rid="B63-nutrients-11-01134" ref-type="bibr">63</xref>]. Finally, although it is still unclear whether a divergent microbiota is a primary phenomenon, the efficacy of therapies such as probiotics and FMT implies that attempts at &#x0201c;correcting&#x0201d; the abnormality lead to at least partial restoration of microbial and GI equilibrium [<xref rid="B64-nutrients-11-01134" ref-type="bibr">64</xref>,<xref rid="B65-nutrients-11-01134" ref-type="bibr">65</xref>].</p></sec><sec id="sec1dot8-nutrients-11-01134"><title>1.8. Impact of Dietary Treatment on the Microbiome in IBS</title><p>Over the past 10 years, clinical trials of the low FODMAP diet have vastly outnumbered studies of other &#x0201d;whole diet&#x0201d; interventions in IBS. Response rates of 50&#x02013;80% are reported in RCTs in which the advice is dietitian-led [<xref rid="B2-nutrients-11-01134" ref-type="bibr">2</xref>]. The impact of short-term FODMAP restriction on the faecal microbiota has been reported in a number of trials of dietary advice in free-living individuals with IBS [<xref rid="B65-nutrients-11-01134" ref-type="bibr">65</xref>,<xref rid="B66-nutrients-11-01134" ref-type="bibr">66</xref>,<xref rid="B67-nutrients-11-01134" ref-type="bibr">67</xref>,<xref rid="B68-nutrients-11-01134" ref-type="bibr">68</xref>,<xref rid="B69-nutrients-11-01134" ref-type="bibr">69</xref>] and in a highly controlled feeding trial [<xref rid="B70-nutrients-11-01134" ref-type="bibr">70</xref>]. A variety of taxonomic changes have been reported, of which the most consistent finding is a lower relative or absolute abundance of <italic>Bifidobacteria</italic> compared with controls and/or pre-intervention [<xref rid="B65-nutrients-11-01134" ref-type="bibr">65</xref>,<xref rid="B66-nutrients-11-01134" ref-type="bibr">66</xref>,<xref rid="B67-nutrients-11-01134" ref-type="bibr">67</xref>,<xref rid="B69-nutrients-11-01134" ref-type="bibr">69</xref>,<xref rid="B70-nutrients-11-01134" ref-type="bibr">70</xref>,<xref rid="B71-nutrients-11-01134" ref-type="bibr">71</xref>]. Interestingly, those individuals with greater <italic>Bifidobacteria</italic> abundance at baseline exhibit the greatest depletion in response to FODMAP restriction [<xref rid="B65-nutrients-11-01134" ref-type="bibr">65</xref>]. Altered metabolomic profile in response to FODMAP restriction has also been reported in IBS, suggesting there is a change in metabolic activity of microbes in response to reduced availability of fermentable carbohydrates or increased availability of alternative dietary substrates [<xref rid="B67-nutrients-11-01134" ref-type="bibr">67</xref>,<xref rid="B71-nutrients-11-01134" ref-type="bibr">71</xref>]. Whether these microbial changes are key to inducing symptomatic response to a low FODMAP diet is not known from the current evidence. The anti-bifidogenic effect of the low FODMAP diet is inconsistent with a &#x0201c;more is better&#x0201d; hypothesis that could be postulated from the inverse correlation between <italic>Bifidobacteria</italic> and symptom severity [<xref rid="B48-nutrients-11-01134" ref-type="bibr">48</xref>,<xref rid="B57-nutrients-11-01134" ref-type="bibr">57</xref>] and the trend toward efficacy of <italic>Bifidobacteria</italic>-containing probiotic supplements in IBS [<xref rid="B72-nutrients-11-01134" ref-type="bibr">72</xref>].</p></sec><sec id="sec1dot9-nutrients-11-01134"><title>1.9. Microbiome as a Predictor for Dietary Treatment Response in IBS</title><p>The ability to predict symptomatic response to the low FODMAP diet has been of recent interest, particularly considering the diet is intensive to implement and requires dietetic supervision [<xref rid="B73-nutrients-11-01134" ref-type="bibr">73</xref>], and that up to half of individuals may not benefit. There is limited but consistent evidence that baseline demographic or clinical characteristics do not differentiate responders from non-responders to the low FODMAP diet [<xref rid="B68-nutrients-11-01134" ref-type="bibr">68</xref>,<xref rid="B74-nutrients-11-01134" ref-type="bibr">74</xref>,<xref rid="B75-nutrients-11-01134" ref-type="bibr">75</xref>,<xref rid="B76-nutrients-11-01134" ref-type="bibr">76</xref>].</p><p>Five studies have investigated whether baseline microbiota could predict symptomatic response to the low FODMAP diet (<xref rid="nutrients-11-01134-t002" ref-type="table">Table 2</xref>). One four-week RCT (19/33 responders, 61%) [<xref rid="B5-nutrients-11-01134" ref-type="bibr">5</xref>] and a four-week uncontrolled trial (32/61 responders, 52%) [<xref rid="B77-nutrients-11-01134" ref-type="bibr">77</xref>] of low FODMAP dietary advice propose baseline microbial profile to be predictive of response, using a microbial mapping technique based on selected DNA probes [<xref rid="B78-nutrients-11-01134" ref-type="bibr">78</xref>]. Of the 45 bacterial markers at baseline in the latter trial, 10 differentiated responders from non-responders with a positive predictive value of 76.0 (95% CI 61&#x02013;87) using scores based on an arbitrary microbial &#x0201c;response index&#x0201d;. A third study, a small uncontrolled one-week trial in children (4/8 responders, 50%), reported that a lower abundance of saccharolytic <italic>Bacteroides</italic> and Bacteroidales was predictive of dietary response [<xref rid="B68-nutrients-11-01134" ref-type="bibr">68</xref>]. This was followed by a crossover RCT (8/33 responders, 24%) that reported baseline enrichment of a range of saccharolytic taxa including <italic>Bacteroides</italic> and <italic>Faecalibacterium prausnitzii</italic> in responders compared with non-responders [<xref rid="B79-nutrients-11-01134" ref-type="bibr">79</xref>]. However, not all studies report positive findings; one trial found no predictive value of baseline microbiota in determining clinical response to a low FODMAP diet, although the highly controlled four-week feeding RCT in adults (11/27 responders, 41%) based findings on abundances of a select few taxa using qPCR analysis. It must also be noted that both trials of crossover design may have influenced microbial composition of those receiving low FODMAP diet as the second intervention [<xref rid="B68-nutrients-11-01134" ref-type="bibr">68</xref>,<xref rid="B70-nutrients-11-01134" ref-type="bibr">70</xref>].</p><p>There are obvious challenges in interpreting the evidence from these trials. Pre-intervention environmental factors (e.g., medication, probiotic intake) that could impact on baseline microbiota composition are not always reported or controlled. Heterogeneity in baseline stool consistency and psychological comorbidity, both associated with altered microbiota composition [<xref rid="B47-nutrients-11-01134" ref-type="bibr">47</xref>,<xref rid="B80-nutrients-11-01134" ref-type="bibr">80</xref>,<xref rid="B81-nutrients-11-01134" ref-type="bibr">81</xref>], also complicate the identification of a distinct &#x0201c;responder&#x0201d; microbiota. Second, the stringency of low FODMAP dietary advice varies between studies. Insufficient FODMAP restriction could lead to an underestimation of true responders. Furthermore, clinical response criteria vary across studies, ranging from validated criteria [<xref rid="B5-nutrients-11-01134" ref-type="bibr">5</xref>,<xref rid="B77-nutrients-11-01134" ref-type="bibr">77</xref>] through to arbitrary cut-offs [<xref rid="B70-nutrients-11-01134" ref-type="bibr">70</xref>], leading to a sizable range of symptom severities in &#x0201c;responders&#x0201d; after low FODMAP treatment. Finally, no two studies so far have utilised the same statistical modelling techniques to explore the potential of microbiota as a predictor; ideally, the choice of statistical approach should be made by an independent blinded researcher to enable objective and statistically rigorous findings.</p><p>Based on the literature thus far, there is inconsistent evidence to support the use of one baseline microbiota signature to accurately predict response to a low FODMAP diet. Evidence that a baseline bacterial volatile organic compound profile may very accurately select responders [<xref rid="B82-nutrients-11-01134" ref-type="bibr">82</xref>] suggests the possibility that the metabolic function of bacteria may be important in determining response. Validation studies in well-controlled studies of specific IBS subtypes are warranted.</p></sec></sec><sec id="sec2-nutrients-11-01134"><title>2. General Discussion and Limitations</title><p>Few human studies (summarised in <xref rid="nutrients-11-01134-t001" ref-type="table">Table 1</xref> and <xref rid="nutrients-11-01134-t002" ref-type="table">Table 2</xref>) have been conducted investigating whether specific microbial signatures predict response to dietary interventions. The conditions of obesity and IBS represent the best examples of preliminary work conducted in this area. Based on this review, there is inconsistent evidence to support the existence of specific microbiota signatures to accurately predict clinical response to dietary intervention in obesity and IBS. A number of limitations still impede progress in this sphere of research.</p><p>First, microbial sampling (i.e., faecal or biopsy) and quantification methodologies applied across studies thus far have been inconsistent. The increasing power and sensitivity of modern sequencing techniques has led to the rapid development of high-throughput methods for assessing genome-wide genetic variations. However, the approaches used to characterise the human microbiota still vary widely. Furthermore, technical accuracy is crucial throughout processing and analysis. For example, the suboptimal mechanical lysis during extraction of the microbiota DNA from faecal or biopsy samples, a key step in the analysis pipeline [<xref rid="B83-nutrients-11-01134" ref-type="bibr">83</xref>], will distort the downstream analysis more than any other analysis step.</p><p>Second, there are several shortcomings in the predictive modelling analysis methods utilised. Therefore, it is important that consistent analysis pipelines be adopted worldwide enabling comparison of data between studies. Studies may be limited to exploratory statistical analysis until clinical studies can be adequately designed and powered for primary analysis.</p><p>Third, there are many problematic confounding factors that can impact on baseline microbiota composition. These factors include, but are not limited to, the host genetic makeup, long-term dietary habits, ethnicity, sanitation, geographical location, exercise and lifestyle habits, and antibiotic use. This further highlights the conclusion that any personalised predictive model incorporating gut microbial composition must consider multiple additional relevant individual datapoints, which may vary with disease state. It is also acknowledged that some chronic diseases, although benefiting from dietary intervention, may never be amenable to a microbiota-based personalised nutrition approach due to inherent heterogeneity in microbiota composition across individuals.</p><p>Finally, for ultimate translation into clinical practice, there is a need to understand if the results gained from short-term studies predicting host response can be translated into durable responses over time, leading to long-term positive health outcomes. Longer duration of studies and intervention periods are also needed.</p></sec><sec sec-type="conclusions" id="sec3-nutrients-11-01134"><title>3. Conclusions</title><p>Diet is one of the most important determinants of the gut microbiota composition. However, the relationship between diet and microbiota is complex and not completely understood. Consequently, personalised nutrition models that predict clinical response to dietary treatment based on the microbial composition are still extremely challenging to test in the research context. Some evidence of associations between gut microbiota and response to dietary treatments for both obesity and IBS suggests that links exist between microbiota composition and inter-individuality in host response to diet. However, personalised nutrition research is in its infancy and specific microbiota signatures that predict individualised responses to dietary treatment are still elusive; advancements in analysis technologies and consistent bioinformatic approaches will be important for progress.</p></sec></body><back><notes><title>Author Contributions</title><p>Conceptualisation, writing, draft preparation, review and editing: J.R.B., J.J. and H.M.S.</p></notes><notes><title>Funding</title><p>Jonna Jalanka was supported by a Fellowship from the Finnish Academy (Grant No. 0313471-7). Heidi Staudacher was supported by an Alfred Deakin Postdoctoral Fellowship.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALT</td><td align="left" valign="middle" rowspan="1" colspan="1">Alanine aminotransferase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FMT</td><td align="left" valign="middle" rowspan="1" colspan="1">Faecal microbiota transplant</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FODMAP</td><td align="left" valign="middle" rowspan="1" colspan="1">Fermentable oligo-, di-, monosaccharides and polyols</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IBS</td><td align="left" valign="middle" rowspan="1" colspan="1">Irritable bowel syndrome</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PPGR</td><td align="left" valign="middle" rowspan="1" colspan="1">Postprandial glycaemic response</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RCT</td><td align="left" valign="middle" rowspan="1" colspan="1">Randomised clinical trial</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RNA</td><td align="left" valign="middle" rowspan="1" colspan="1">Ribonucleic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SCFA</td><td align="left" valign="middle" rowspan="1" colspan="1">Short-chain fatty acid</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-nutrients-11-01134"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kris-Etherton</surname><given-names>P.M.</given-names></name><name><surname>Etherton</surname><given-names>T.D.</given-names></name><name><surname>Carlson</surname><given-names>J.</given-names></name><name><surname>Gardner</surname><given-names>C.</given-names></name></person-group><article-title>Recent discoveries in inclusive food-based approaches and dietary patterns for reduction in risk for cardiovascular disease</article-title><source>Curr. Opin. Lipidol.</source><year>2002</year><volume>13</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1097/00041433-200208000-00007</pub-id><pub-id pub-id-type="pmid">12151855</pub-id></element-citation></ref><ref id="B2-nutrients-11-01134"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staudacher</surname><given-names>H.M.</given-names></name><name><surname>Whelan</surname><given-names>K.</given-names></name></person-group><article-title>The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS</article-title><source>Gut</source><year>2017</year><volume>66</volume><fpage>1517</fpage><lpage>1527</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2017-313750</pub-id><pub-id pub-id-type="pmid">28592442</pub-id></element-citation></ref><ref id="B3-nutrients-11-01134"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seganfredo</surname><given-names>F.B.</given-names></name><name><surname>Blume</surname><given-names>C.A.</given-names></name><name><surname>Moehlecke</surname><given-names>M.</given-names></name><name><surname>Giongo</surname><given-names>A.</given-names></name><name><surname>Casagrande</surname><given-names>D.S.</given-names></name><name><surname>Spolidoro</surname><given-names>J.V.N.</given-names></name><name><surname>Padoin</surname><given-names>A.V.</given-names></name><name><surname>Schaan</surname><given-names>B.D.</given-names></name><name><surname>Mottin</surname><given-names>C.C.</given-names></name></person-group><article-title>Weight-loss interventions and gut microbiota changes in overweight and obese patients: A systematic review</article-title><source>Obes. Rev.</source><year>2017</year><volume>18</volume><fpage>832</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1111/obr.12541</pub-id><pub-id pub-id-type="pmid">28524627</pub-id></element-citation></ref><ref id="B4-nutrients-11-01134"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMillan-Price</surname><given-names>J.</given-names></name><name><surname>Petocz</surname><given-names>P.</given-names></name><name><surname>Atkinson</surname><given-names>F.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>K.</given-names></name><name><surname>Samman</surname><given-names>S.</given-names></name><name><surname>Steinbeck</surname><given-names>K.</given-names></name><name><surname>Caterson</surname><given-names>I.</given-names></name><name><surname>Brand-Miller</surname><given-names>J.J.</given-names></name></person-group><article-title>Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: A randomized controlled trial</article-title><source>Arch. Intern. Med.</source><year>2006</year><volume>166</volume><fpage>1466</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.1001/archinte.166.14.1466</pub-id><pub-id pub-id-type="pmid">16864756</pub-id></element-citation></ref><ref id="B5-nutrients-11-01134"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennet</surname><given-names>S.M.P.</given-names></name><name><surname>Bohn</surname><given-names>L.</given-names></name><name><surname>Storsrud</surname><given-names>S.</given-names></name><name><surname>Liljebo</surname><given-names>T.</given-names></name><name><surname>Collin</surname><given-names>L.</given-names></name><name><surname>Lindfors</surname><given-names>P.</given-names></name><name><surname>Tornblom</surname><given-names>H.</given-names></name><name><surname>Ohman</surname><given-names>L.</given-names></name><name><surname>Simren</surname><given-names>M.</given-names></name></person-group><article-title>Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs</article-title><source>Gut</source><year>2018</year><volume>67</volume><fpage>872</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2016-313128</pub-id><pub-id pub-id-type="pmid">28416515</pub-id></element-citation></ref><ref id="B6-nutrients-11-01134"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeevi</surname><given-names>D.</given-names></name><name><surname>Korem</surname><given-names>T.</given-names></name><name><surname>Zmora</surname><given-names>N.</given-names></name><name><surname>Israeli</surname><given-names>D.</given-names></name><name><surname>Rothschild</surname><given-names>D.</given-names></name><name><surname>Weinberger</surname><given-names>A.</given-names></name><name><surname>Ben-Yacov</surname><given-names>O.</given-names></name><name><surname>Lador</surname><given-names>D.</given-names></name><name><surname>Avnit-Sagi</surname><given-names>T.</given-names></name><name><surname>Lotan-Pompan</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Personalized Nutrition by Prediction of Glycemic Responses</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>1079</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.11.001</pub-id><pub-id pub-id-type="pmid">26590418</pub-id></element-citation></ref><ref id="B7-nutrients-11-01134"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vos</surname><given-names>W.M.</given-names></name><name><surname>de Vos</surname><given-names>E.A.</given-names></name></person-group><article-title>Role of the intestinal microbiome in health and disease: From correlation to causation</article-title><source>Nutr. Rev.</source><year>2012</year><volume>70</volume><fpage>S45</fpage><lpage>S56</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2012.00505.x</pub-id><pub-id pub-id-type="pmid">22861807</pub-id></element-citation></ref><ref id="B8-nutrients-11-01134"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonze</surname><given-names>D.</given-names></name><name><surname>Coyte</surname><given-names>K.Z.</given-names></name><name><surname>Lahti</surname><given-names>L.</given-names></name><name><surname>Faust</surname><given-names>K.</given-names></name></person-group><article-title>Microbial communities as dynamical systems</article-title><source>Curr. Opin. Microbiol.</source><year>2018</year><volume>44</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2018.07.004</pub-id><pub-id pub-id-type="pmid">30041083</pub-id></element-citation></ref><ref id="B9-nutrients-11-01134"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faith</surname><given-names>J.J.</given-names></name><name><surname>McNulty</surname><given-names>N.P.</given-names></name><name><surname>Rey</surname><given-names>F.E.</given-names></name><name><surname>Gordon</surname><given-names>J.I.</given-names></name></person-group><article-title>Predicting a human gut microbiota&#x02019;s response to diet in gnotobiotic mice</article-title><source>Science</source><year>2011</year><volume>333</volume><fpage>101</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1126/science.1206025</pub-id><pub-id pub-id-type="pmid">21596954</pub-id></element-citation></ref><ref id="B10-nutrients-11-01134"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salonen</surname><given-names>A.</given-names></name><name><surname>Lahti</surname><given-names>L.</given-names></name><name><surname>Saloj&#x000e4;rvi</surname><given-names>J.</given-names></name><name><surname>Holtrop</surname><given-names>G.</given-names></name><name><surname>Korpela</surname><given-names>K.</given-names></name><name><surname>Duncan</surname><given-names>S.H.</given-names></name><name><surname>Date</surname><given-names>P.</given-names></name><name><surname>Farquharson</surname><given-names>F.</given-names></name><name><surname>Johnstone</surname><given-names>A.M.</given-names></name><name><surname>E Lobley</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men</article-title><source>ISME J.</source><year>2014</year><volume>8</volume><fpage>2218</fpage><lpage>2230</lpage><pub-id pub-id-type="doi">10.1038/ismej.2014.63</pub-id><pub-id pub-id-type="pmid">24763370</pub-id></element-citation></ref><ref id="B11-nutrients-11-01134"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuohy</surname><given-names>K.M.</given-names></name><name><surname>Kolida</surname><given-names>S.</given-names></name><name><surname>Lustenberger</surname><given-names>A.M.</given-names></name><name><surname>Gibson</surname><given-names>G.R.</given-names></name><name><surname>Tuohy</surname><given-names>K.</given-names></name></person-group><article-title>The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides- a human volunteer study</article-title><source>Br. J. Nutr.</source><year>2001</year><volume>86</volume><fpage>341</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1079/BJN2001394</pub-id><pub-id pub-id-type="pmid">11570986</pub-id></element-citation></ref><ref id="B12-nutrients-11-01134"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>M.</given-names></name><name><surname>Fleming</surname><given-names>T.</given-names></name><name><surname>Robinson</surname><given-names>M.</given-names></name><name><surname>Thomson</surname><given-names>B.</given-names></name><name><surname>Graetz</surname><given-names>N.</given-names></name><name><surname>Margono</surname><given-names>C.</given-names></name><name><surname>Mullany</surname><given-names>E.C.</given-names></name><name><surname>Biryukov</surname><given-names>S.</given-names></name><name><surname>Abbafati</surname><given-names>C.</given-names></name><name><surname>Abera</surname><given-names>S.F.</given-names></name><etal/></person-group><article-title>Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013</article-title><source>Lancet</source><year>2014</year><volume>384</volume><fpage>766</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60460-8</pub-id><pub-id pub-id-type="pmid">24880830</pub-id></element-citation></ref><ref id="B13-nutrients-11-01134"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meigs</surname><given-names>J.B.</given-names></name><name><surname>Wilson</surname><given-names>P.W.F.</given-names></name><name><surname>Fox</surname><given-names>C.S.</given-names></name><name><surname>Vasan</surname><given-names>R.S.</given-names></name><name><surname>Nathan</surname><given-names>D.M.</given-names></name><name><surname>Sullivan</surname><given-names>L.M.</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>R.B.</given-names></name></person-group><article-title>Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2006</year><volume>91</volume><fpage>2906</fpage><lpage>2912</lpage><pub-id pub-id-type="doi">10.1210/jc.2006-0594</pub-id><pub-id pub-id-type="pmid">16735483</pub-id></element-citation></ref><ref id="B14-nutrients-11-01134"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauby-Secretan</surname><given-names>B.</given-names></name><name><surname>Grosse</surname><given-names>Y.</given-names></name><name><surname>Bianchini</surname><given-names>F.</given-names></name><name><surname>Loomis</surname><given-names>D.</given-names></name><name><surname>Straif</surname><given-names>K.</given-names></name><name><surname>Scoccianti</surname><given-names>C.</given-names></name></person-group><article-title>Body Fatness and Cancer&#x02013;Viewpoint of the IARC Working Group</article-title><source>N. Engl. J. Med.</source><year>2016</year><volume>375</volume><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1056/NEJMsr1606602</pub-id><pub-id pub-id-type="pmid">27557308</pub-id></element-citation></ref><ref id="B15-nutrients-11-01134"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sackner-Bernstein</surname><given-names>J.</given-names></name><name><surname>Kanter</surname><given-names>D.</given-names></name><name><surname>Kaul</surname><given-names>S.</given-names></name></person-group><article-title>Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0139817</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0139817</pub-id><pub-id pub-id-type="pmid">26485706</pub-id></element-citation></ref><ref id="B16-nutrients-11-01134"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>S.</given-names></name><name><surname>Shirani</surname><given-names>F.</given-names></name><name><surname>Chitsazi</surname><given-names>M.J.</given-names></name><name><surname>Salehi-Abargouei</surname><given-names>A.</given-names></name></person-group><article-title>The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: A systematic review and meta-analysis of randomized controlled clinical trials</article-title><source>Obes. Rev.</source><year>2016</year><volume>17</volume><fpage>442</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1111/obr.12391</pub-id><pub-id pub-id-type="pmid">26990451</pub-id></element-citation></ref><ref id="B17-nutrients-11-01134"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacy</surname><given-names>B.E.</given-names></name><name><surname>Mearin</surname><given-names>F.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Chey</surname><given-names>W.D.</given-names></name><name><surname>Lembo</surname><given-names>A.J.</given-names></name><name><surname>Simr&#x000e9;n</surname><given-names>M.</given-names></name><name><surname>Spiller</surname><given-names>R.</given-names></name></person-group><article-title>Bowel Disorders</article-title><source>Gastroenterology</source><year>2016</year><volume>150</volume><fpage>1393</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2016.02.031</pub-id></element-citation></ref><ref id="B18-nutrients-11-01134"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovell</surname><given-names>R.M.</given-names></name><name><surname>Ford</surname><given-names>A.C.</given-names></name></person-group><article-title>Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2012</year><volume>10</volume><fpage>712</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2012.02.029</pub-id><pub-id pub-id-type="pmid">22426087</pub-id></element-citation></ref><ref id="B19-nutrients-11-01134"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>A.C.</given-names></name><name><surname>Moayyedi</surname><given-names>P.</given-names></name><name><surname>Chey</surname><given-names>W.D.</given-names></name><name><surname>Harris</surname><given-names>L.A.</given-names></name><name><surname>Lacy</surname><given-names>B.E.</given-names></name><name><surname>Saito</surname><given-names>Y.A.</given-names></name><name><surname>Quigley</surname><given-names>E.M.M.</given-names></name></person-group><article-title>American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome</article-title><source>Am. J. Gastroenterol.</source><year>2018</year><volume>113</volume><issue>Suppl. S2</issue><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1038/s41395-018-0084-x</pub-id></element-citation></ref><ref id="B20-nutrients-11-01134"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>Y.A.</given-names></name><name><surname>Bowyer</surname><given-names>R.K.</given-names></name><name><surname>Leach</surname><given-names>H.</given-names></name><name><surname>Gulia</surname><given-names>P.</given-names></name><name><surname>Horobin</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>N.A.</given-names></name><name><surname>Pettitt</surname><given-names>C.</given-names></name><name><surname>Reeves</surname><given-names>L.B.</given-names></name><name><surname>Seamark</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>M.</given-names></name><etal/></person-group><article-title>British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults</article-title><source>J. Hum. Nutr. Diet.</source><year>2016</year><volume>29</volume><fpage>549</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1111/jhn.12385</pub-id><pub-id pub-id-type="pmid">27272325</pub-id></element-citation></ref><ref id="B21-nutrients-11-01134"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>R.E.</given-names></name><name><surname>Turnbaugh</surname><given-names>P.J.</given-names></name><name><surname>Klein</surname><given-names>S.</given-names></name><name><surname>Gordon</surname><given-names>J.I.</given-names></name></person-group><article-title>Microbial ecology: Human gut microbes associated with obesity</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>1022</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1038/4441022a</pub-id><pub-id pub-id-type="pmid">17183309</pub-id></element-citation></ref><ref id="B22-nutrients-11-01134"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plovier</surname><given-names>H.</given-names></name><name><surname>Everard</surname><given-names>A.</given-names></name><name><surname>Druart</surname><given-names>C.</given-names></name><name><surname>Depommier</surname><given-names>C.</given-names></name><name><surname>Van Hul</surname><given-names>M.</given-names></name><name><surname>Geurts</surname><given-names>L.</given-names></name><name><surname>Chilloux</surname><given-names>J.</given-names></name><name><surname>Ottman</surname><given-names>N.</given-names></name><name><surname>Duparc</surname><given-names>T.</given-names></name><name><surname>Lichtenstein</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice</article-title><source>Nat. Med.</source><year>2017</year><volume>23</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/nm.4236</pub-id><pub-id pub-id-type="pmid">27892954</pub-id></element-citation></ref><ref id="B23-nutrients-11-01134"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.K.</given-names></name><name><surname>Chang</surname><given-names>H.-W.</given-names></name><name><surname>Yan</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>K.M.</given-names></name><name><surname>Ucmak</surname><given-names>D.</given-names></name><name><surname>Wong</surname><given-names>K.</given-names></name><name><surname>Abrouk</surname><given-names>M.</given-names></name><name><surname>Farahnik</surname><given-names>B.</given-names></name><name><surname>Nakamura</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>T.H.</given-names></name><etal/></person-group><article-title>Influence of diet on the gut microbiome and implications for human health</article-title><source>J. Transl. Med.</source><year>2017</year><volume>15</volume><fpage>73</fpage><pub-id pub-id-type="doi">10.1186/s12967-017-1175-y</pub-id><pub-id pub-id-type="pmid">28388917</pub-id></element-citation></ref><ref id="B24-nutrients-11-01134"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Chatelier</surname><given-names>E.</given-names></name><collab>MetaHIT Consortium</collab><name><surname>Nielsen</surname><given-names>T.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Prifti</surname><given-names>E.</given-names></name><name><surname>Hildebrand</surname><given-names>F.</given-names></name><name><surname>Falony</surname><given-names>G.</given-names></name><name><surname>Almeida</surname><given-names>M.</given-names></name><name><surname>Arumugam</surname><given-names>M.</given-names></name><name><surname>Batto</surname><given-names>J.-M.</given-names></name><etal/></person-group><article-title>Richness of human gut microbiome correlates with metabolic markers</article-title><source>Nature</source><year>2013</year><volume>500</volume><fpage>541</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">23985870</pub-id></element-citation></ref><ref id="B25-nutrients-11-01134"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgeraas</surname><given-names>H.</given-names></name><name><surname>Johnson</surname><given-names>L.K.</given-names></name><name><surname>Skattebu</surname><given-names>J.</given-names></name><name><surname>Hertel</surname><given-names>J.K.</given-names></name><name><surname>Hjelmesaeth</surname><given-names>J.</given-names></name></person-group><article-title>Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials</article-title><source>Obes. Rev.</source><year>2018</year><volume>19</volume><fpage>219</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1111/obr.12626</pub-id><pub-id pub-id-type="pmid">29047207</pub-id></element-citation></ref><ref id="B26-nutrients-11-01134"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrieze</surname><given-names>A.</given-names></name><name><surname>Van Nood</surname><given-names>E.</given-names></name><name><surname>Holleman</surname><given-names>F.</given-names></name><name><surname>Saloj&#x000e4;rvi</surname><given-names>J.</given-names></name><name><surname>Kootte</surname><given-names>R.S.</given-names></name><name><surname>Bartelsman</surname><given-names>J.F.</given-names></name><name><surname>Dallinga&#x02013;Thie</surname><given-names>G.M.</given-names></name><name><surname>Ackermans</surname><given-names>M.T.</given-names></name><name><surname>Serlie</surname><given-names>M.J.</given-names></name><name><surname>Oozeer</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Transfer of Intestinal Microbiota from Lean Donors Increases Insulin Sensitivity in Individuals with Metabolic Syndrome</article-title><source>Gastroenterology</source><year>2012</year><volume>143</volume><fpage>913</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2012.06.031</pub-id><pub-id pub-id-type="pmid">22728514</pub-id></element-citation></ref><ref id="B27-nutrients-11-01134"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.V.</given-names></name><name><surname>Frassetto</surname><given-names>A.</given-names></name><name><surname>Kowalik</surname><given-names>E.J.</given-names><suffix>Jr.</suffix></name><name><surname>Nawrocki</surname><given-names>A.R.</given-names></name><name><surname>Lu</surname><given-names>M.M.</given-names></name><name><surname>Kosinski</surname><given-names>J.R.</given-names></name><name><surname>Hubert</surname><given-names>J.A.</given-names></name><name><surname>Szeto</surname><given-names>D.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Forrest</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e35240</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0035240</pub-id><pub-id pub-id-type="pmid">22506074</pub-id></element-citation></ref><ref id="B28-nutrients-11-01134"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e4;ckhed</surname><given-names>F.</given-names></name><name><surname>Manchester</surname><given-names>J.K.</given-names></name><name><surname>Semenkovich</surname><given-names>C.F.</given-names></name><name><surname>Gordon</surname><given-names>J.I.</given-names></name></person-group><article-title>Mechanisms underlying the resistance to diet-induced obesity in germ-free mice</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>979</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1073/pnas.0605374104</pub-id><pub-id pub-id-type="pmid">17210919</pub-id></element-citation></ref><ref id="B29-nutrients-11-01134"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wellen</surname><given-names>K.E.</given-names></name><name><surname>Hotamisligil</surname><given-names>G.S.</given-names></name></person-group><article-title>Inflammation, stress, and diabetes</article-title><source>J. Clin. Investig.</source><year>2005</year><volume>115</volume><fpage>1111</fpage><lpage>1119</lpage><pub-id pub-id-type="doi">10.1172/JCI25102</pub-id><pub-id pub-id-type="pmid">15864338</pub-id></element-citation></ref><ref id="B30-nutrients-11-01134"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>G.W.</given-names></name><name><surname>Oh</surname><given-names>S.</given-names></name><name><surname>Park</surname><given-names>M.</given-names></name><name><surname>Gang</surname><given-names>G.</given-names></name><name><surname>McLean</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>H.S.</given-names></name><name><surname>Song</surname><given-names>M.H.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name></person-group><article-title>t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation</article-title><source>J. Microbiol. Biotechnol.</source><year>2013</year><volume>23</volume><fpage>1569</fpage><lpage>1576</lpage><pub-id pub-id-type="doi">10.4014/jmb.1308.08008</pub-id><pub-id pub-id-type="pmid">24018969</pub-id></element-citation></ref><ref id="B31-nutrients-11-01134"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijay-Kumar</surname><given-names>M.</given-names></name><name><surname>Aitken</surname><given-names>J.D.</given-names></name><name><surname>Carvalho</surname><given-names>F.A.</given-names></name><name><surname>Cullender</surname><given-names>T.C.</given-names></name><name><surname>Mwangi</surname><given-names>S.</given-names></name><name><surname>Srinivasan</surname><given-names>S.</given-names></name><name><surname>Sitaraman</surname><given-names>S.V.</given-names></name><name><surname>Knight</surname><given-names>R.</given-names></name><name><surname>Ley</surname><given-names>R.E.</given-names></name><name><surname>Gewirtz</surname><given-names>A.T.</given-names></name></person-group><article-title>Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5</article-title><source>Science</source><year>2010</year><volume>328</volume><fpage>228</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1126/science.1179721</pub-id><pub-id pub-id-type="pmid">20203013</pub-id></element-citation></ref><ref id="B32-nutrients-11-01134"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinsen</surname><given-names>F.-A.</given-names></name><name><surname>Fangmann</surname><given-names>D.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>N.</given-names></name><name><surname>Schulte</surname><given-names>D.M.</given-names></name><name><surname>R&#x000fc;hlemann</surname><given-names>M.C.</given-names></name><name><surname>T&#x000fc;rk</surname><given-names>K.</given-names></name><name><surname>Settgast</surname><given-names>U.</given-names></name><name><surname>Lieb</surname><given-names>W.</given-names></name><name><surname>Baines</surname><given-names>J.F.</given-names></name><name><surname>Schreiber</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Beneficial Effects of a Dietary Weight Loss Intervention on Human Gut Microbiome Diversity and Metabolism Are Not Sustained during Weight Maintenance</article-title><source>Obes. Facts</source><year>2016</year><volume>9</volume><fpage>379</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1159/000449506</pub-id><pub-id pub-id-type="pmid">27898428</pub-id></element-citation></ref><ref id="B33-nutrients-11-01134"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotillard</surname><given-names>A.</given-names></name><collab>ANR MicroObes Consortium</collab><name><surname>Kennedy</surname><given-names>S.P.</given-names></name><name><surname>Kong</surname><given-names>L.C.</given-names></name><name><surname>Prifti</surname><given-names>E.</given-names></name><name><surname>Pons</surname><given-names>N.</given-names></name><name><surname>Le Chatelier</surname><given-names>E.</given-names></name><name><surname>Almeida</surname><given-names>M.</given-names></name><name><surname>Quinquis</surname><given-names>B.</given-names></name><name><surname>Levenez</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Dietary intervention impact on gut microbial gene richness</article-title><source>Nature</source><year>2013</year><volume>500</volume><fpage>585</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">23985875</pub-id></element-citation></ref><ref id="B34-nutrients-11-01134"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haro</surname><given-names>C.</given-names></name><name><surname>Montes-Borrego</surname><given-names>M.</given-names></name><name><surname>Rangel-Z&#x000fa;&#x000f1;iga</surname><given-names>O.A.</given-names></name><name><surname>Alcala-Diaz</surname><given-names>J.F.</given-names></name><name><surname>Gomez-Delgado</surname><given-names>F.</given-names></name><name><surname>Perez-Martinez</surname><given-names>P.</given-names></name><name><surname>Delgado-Lista</surname><given-names>J.</given-names></name><name><surname>Quintana-Navarro</surname><given-names>G.M.</given-names></name><name><surname>Tinahones</surname><given-names>F.J.</given-names></name><name><surname>Landa</surname><given-names>B.B.</given-names></name><etal/></person-group><article-title>Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2016</year><volume>101</volume><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1210/jc.2015-3351</pub-id><pub-id pub-id-type="pmid">26505825</pub-id></element-citation></ref><ref id="B35-nutrients-11-01134"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolucci</surname><given-names>A.C.</given-names></name><name><surname>Hume</surname><given-names>M.P.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>I.</given-names></name><name><surname>Mayengbam</surname><given-names>S.</given-names></name><name><surname>Walter</surname><given-names>J.</given-names></name><name><surname>Reimer</surname><given-names>R.A.</given-names></name></person-group><article-title>Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or with Obesity</article-title><source>Gastroenterology</source><year>2017</year><volume>153</volume><fpage>711</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2017.05.055</pub-id><pub-id pub-id-type="pmid">28596023</pub-id></element-citation></ref><ref id="B36-nutrients-11-01134"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Yin</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Ouyang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children</article-title><source>EBioMedicine</source><year>2015</year><volume>2</volume><fpage>968</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2015.07.007</pub-id><pub-id pub-id-type="pmid">26425705</pub-id></element-citation></ref><ref id="B37-nutrients-11-01134"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dao</surname><given-names>M.C.</given-names></name><name><surname>Everard</surname><given-names>A.</given-names></name><name><surname>Aron-Wisnewsky</surname><given-names>J.</given-names></name><name><surname>Sokolovska</surname><given-names>N.</given-names></name><name><surname>Prifti</surname><given-names>E.</given-names></name><name><surname>Verger</surname><given-names>E.O.</given-names></name><name><surname>Kayser</surname><given-names>B.D.</given-names></name><name><surname>Levenez</surname><given-names>F.</given-names></name><name><surname>Chilloux</surname><given-names>J.</given-names></name><name><surname>Hoyles</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology</article-title><source>Gut</source><year>2016</year><volume>65</volume><fpage>426</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2014-308778</pub-id><pub-id pub-id-type="pmid">26100928</pub-id></element-citation></ref><ref id="B38-nutrients-11-01134"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>L.C.</given-names></name><name><surname>Wuillemin</surname><given-names>P.-H.</given-names></name><name><surname>Bastard</surname><given-names>J.-P.</given-names></name><name><surname>Sokolovska</surname><given-names>N.</given-names></name><name><surname>Gougis</surname><given-names>S.</given-names></name><name><surname>Fellahi</surname><given-names>S.</given-names></name><name><surname>Darakhshan</surname><given-names>F.</given-names></name><name><surname>Bonnefont-Rousselot</surname><given-names>D.</given-names></name><name><surname>Bittar</surname><given-names>R.</given-names></name><name><surname>Dor&#x000e9;</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach</article-title><source>Am. J. Clin. Nutr.</source><year>2013</year><volume>98</volume><fpage>1385</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.3945/ajcn.113.058099</pub-id><pub-id pub-id-type="pmid">24172304</pub-id></element-citation></ref><ref id="B39-nutrients-11-01134"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korpela</surname><given-names>K.</given-names></name><name><surname>Flint</surname><given-names>H.J.</given-names></name><name><surname>Johnstone</surname><given-names>A.M.</given-names></name><name><surname>Lappi</surname><given-names>J.</given-names></name><name><surname>Poutanen</surname><given-names>K.</given-names></name><name><surname>Dewulf</surname><given-names>E.</given-names></name><name><surname>Delzenne</surname><given-names>N.</given-names></name><name><surname>De Vos</surname><given-names>W.M.</given-names></name><name><surname>Salonen</surname><given-names>A.</given-names></name></person-group><article-title>Gut Microbiota Signatures Predict Host and Microbiota Responses to Dietary Interventions in Obese Individuals</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e90702</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0090702</pub-id><pub-id pub-id-type="pmid">24603757</pub-id></element-citation></ref><ref id="B40-nutrients-11-01134"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovatcheva-Datchary</surname><given-names>P.</given-names></name><name><surname>Nilsson</surname><given-names>A.</given-names></name><name><surname>Akrami</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>Y.S.</given-names></name><name><surname>De Vadder</surname><given-names>F.</given-names></name><name><surname>Arora</surname><given-names>T.</given-names></name><name><surname>Hall&#x000e9;n</surname><given-names>A.</given-names></name><name><surname>Martens</surname><given-names>E.</given-names></name><name><surname>Bj&#x000f6;rck</surname><given-names>I.</given-names></name><name><surname>B&#x000e4;ckhed</surname><given-names>F.</given-names></name></person-group><article-title>Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella</article-title><source>Cell Metab.</source><year>2015</year><volume>22</volume><fpage>971</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.10.001</pub-id><pub-id pub-id-type="pmid">26552345</pub-id></element-citation></ref><ref id="B41-nutrients-11-01134"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korem</surname><given-names>T.</given-names></name><name><surname>Zeevi</surname><given-names>D.</given-names></name><name><surname>Zmora</surname><given-names>N.</given-names></name><name><surname>Weissbrod</surname><given-names>O.</given-names></name><name><surname>Bar</surname><given-names>N.</given-names></name><name><surname>Lotan-Pompan</surname><given-names>M.</given-names></name><name><surname>Avnit-Sagi</surname><given-names>T.</given-names></name><name><surname>Kosower</surname><given-names>N.</given-names></name><name><surname>Malka</surname><given-names>G.</given-names></name><name><surname>Rein</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses</article-title><source>Cell Metab.</source><year>2017</year><volume>25</volume><fpage>1243</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.05.002</pub-id><pub-id pub-id-type="pmid">28591632</pub-id></element-citation></ref><ref id="B42-nutrients-11-01134"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes-Soares</surname><given-names>H.</given-names></name><name><surname>Raveh-Sadka</surname><given-names>T.</given-names></name><name><surname>Azulay</surname><given-names>S.</given-names></name><name><surname>Edens</surname><given-names>K.</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y.</given-names></name><name><surname>Cohen</surname><given-names>Y.</given-names></name><name><surname>Ofek</surname><given-names>T.</given-names></name><name><surname>Bachrach</surname><given-names>D.</given-names></name><name><surname>Stevens</surname><given-names>J.</given-names></name><name><surname>Colibaseanu</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes</article-title><source>JAMA Netw. Open</source><year>2019</year><volume>2</volume><fpage>e188102</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2018.8102</pub-id><pub-id pub-id-type="pmid">30735238</pub-id></element-citation></ref><ref id="B43-nutrients-11-01134"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajili&#x00107;-Stojanovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Jonkers</surname><given-names>D.M.</given-names></name><name><surname>Salonen</surname><given-names>A.</given-names></name><name><surname>Hanevik</surname><given-names>K.</given-names></name><name><surname>Raes</surname><given-names>J.</given-names></name><name><surname>Jalanka</surname><given-names>J.</given-names></name><name><surname>De Vos</surname><given-names>W.M.</given-names></name><name><surname>Manichanh</surname><given-names>C.</given-names></name><name><surname>Golic</surname><given-names>N.</given-names></name><name><surname>Enck</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Intestinal microbiota and diet in IBS: Causes, consequences, or epiphenomena?</article-title><source>Am. J. Gastroenterol.</source><year>2015</year><volume>110</volume><fpage>278</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1038/ajg.2014.427</pub-id><pub-id pub-id-type="pmid">25623659</pub-id></element-citation></ref><ref id="B44-nutrients-11-01134"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittayanon</surname><given-names>R.</given-names></name><name><surname>Lau</surname><given-names>J.T.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Leontiadis</surname><given-names>G.I.</given-names></name><name><surname>Tse</surname><given-names>F.</given-names></name><name><surname>Surette</surname><given-names>M.</given-names></name><name><surname>Moayyedi</surname><given-names>P.</given-names></name></person-group><article-title>Gut Microbiota in Patients with Irritable Bowel Syndrome-a Systematic Review</article-title><source>Gastroenterology</source><year>2019</year><pub-id pub-id-type="doi">10.1053/j.gastro.2019.03.049</pub-id></element-citation></ref><ref id="B45-nutrients-11-01134"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundin</surname><given-names>J.</given-names></name><name><surname>Rangel</surname><given-names>I.</given-names></name><name><surname>Fuentes</surname><given-names>S.</given-names></name><name><surname>Heikamp-de Jong</surname><given-names>I.</given-names></name><name><surname>Hultgren-Hornquist</surname><given-names>E.</given-names></name><name><surname>de Vos</surname><given-names>W.M.</given-names></name><name><surname>Brummer</surname><given-names>R.J.</given-names></name></person-group><article-title>Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress</article-title><source>Aliment. Pharmacol. Ther.</source><year>2015</year><volume>41</volume><fpage>342</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1111/apt.13055</pub-id><pub-id pub-id-type="pmid">25521822</pub-id></element-citation></ref><ref id="B46-nutrients-11-01134"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangel</surname><given-names>I.</given-names></name><name><surname>Sundin</surname><given-names>J.</given-names></name><name><surname>Fuentes</surname><given-names>S.</given-names></name><name><surname>Repsilber</surname><given-names>D.</given-names></name><name><surname>De Vos</surname><given-names>W.M.</given-names></name><name><surname>Brummer</surname><given-names>R.J.</given-names></name></person-group><article-title>The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects</article-title><source>Aliment. Pharmacol. Ther.</source><year>2015</year><volume>42</volume><fpage>1211</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1111/apt.13399</pub-id><pub-id pub-id-type="pmid">26376728</pub-id></element-citation></ref><ref id="B47-nutrients-11-01134"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>I.B.</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>P.W.</given-names></name><name><surname>Ohman</surname><given-names>L.</given-names></name><name><surname>Claesson</surname><given-names>M.J.</given-names></name><name><surname>Deane</surname><given-names>J.</given-names></name><name><surname>Quigley</surname><given-names>E.M.</given-names></name><name><surname>Simren</surname><given-names>M.</given-names></name></person-group><article-title>An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota</article-title><source>Gut</source><year>2012</year><volume>61</volume><fpage>997</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2011-301501</pub-id><pub-id pub-id-type="pmid">22180058</pub-id></element-citation></ref><ref id="B48-nutrients-11-01134"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajili&#x00107;&#x02013;Stojanovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Biagi</surname><given-names>E.</given-names></name><name><surname>Heilig</surname><given-names>H.G.</given-names></name><name><surname>Kajander</surname><given-names>K.</given-names></name><name><surname>Kekkonen</surname><given-names>R.A.</given-names></name><name><surname>Tims</surname><given-names>S.</given-names></name><name><surname>De Vos</surname><given-names>W.M.</given-names></name></person-group><article-title>Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome</article-title><source>Gastroenterology</source><year>2011</year><volume>141</volume><fpage>1792</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2011.07.043</pub-id><pub-id pub-id-type="pmid">21820992</pub-id></element-citation></ref><ref id="B49-nutrients-11-01134"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tap</surname><given-names>J.</given-names></name><name><surname>Derrien</surname><given-names>M.</given-names></name><name><surname>T&#x000f6;rnblom</surname><given-names>H.</given-names></name><name><surname>Brazeilles</surname><given-names>R.</given-names></name><name><surname>Cools-Portier</surname><given-names>S.</given-names></name><name><surname>Dor&#x000e9;</surname><given-names>J.</given-names></name><name><surname>St&#x000f6;rsrud</surname><given-names>S.</given-names></name><name><surname>Le Nev&#x000e9;</surname><given-names>B.</given-names></name><name><surname>&#x000d6;hman</surname><given-names>L.</given-names></name><name><surname>Simr&#x000e9;n</surname><given-names>M.</given-names></name></person-group><article-title>Identification of an Intestinal Microbiota Signature Associated with Severity of Irritable Bowel Syndrome</article-title><source>Gastroenterology</source><year>2017</year><volume>152</volume><fpage>111</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2016.09.049</pub-id><pub-id pub-id-type="pmid">27725146</pub-id></element-citation></ref><ref id="B50-nutrients-11-01134"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Si</surname><given-names>J.-M.</given-names></name><name><surname>Yu</surname><given-names>Y.-C.</given-names></name><name><surname>Fan</surname><given-names>Y.-J.</given-names></name><name><surname>Chen</surname><given-names>S.-J.</given-names></name></person-group><article-title>Intestinal microecology and quality of life in irritable bowel syndrome patients</article-title><source>World J. Gastroenterol.</source><year>2004</year><volume>10</volume><fpage>1802</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.3748/wjg.v10.i12.1802</pub-id><pub-id pub-id-type="pmid">15188510</pub-id></element-citation></ref><ref id="B51-nutrients-11-01134"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerckhoffs</surname><given-names>A.P.</given-names></name><name><surname>Samsom</surname><given-names>M.</given-names></name><name><surname>Van Der Rest</surname><given-names>M.E.</given-names></name><name><surname>De Vogel</surname><given-names>J.</given-names></name><name><surname>Knol</surname><given-names>J.</given-names></name><name><surname>Ben-Amor</surname><given-names>K.</given-names></name><name><surname>Akkermans</surname><given-names>L.M.</given-names></name></person-group><article-title>Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients</article-title><source>World J. Gastroenterol.</source><year>2009</year><volume>15</volume><fpage>2887</fpage><lpage>2892</lpage><pub-id pub-id-type="pmid">19533811</pub-id></element-citation></ref><ref id="B52-nutrients-11-01134"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsari</surname><given-names>A.</given-names></name><name><surname>Ceccarelli</surname><given-names>A.</given-names></name><name><surname>Dubini</surname><given-names>F.</given-names></name><name><surname>Fesce</surname><given-names>E.</given-names></name><name><surname>Poli</surname><given-names>G.</given-names></name></person-group><article-title>The fecal microbial population in the irritable bowel syndrome</article-title><source>Microbiologica</source><year>1982</year><volume>5</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">7121297</pub-id></element-citation></ref><ref id="B53-nutrients-11-01134"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malinen</surname><given-names>E.</given-names></name><name><surname>Rinttil&#x000e4;</surname><given-names>T.</given-names></name><name><surname>Kajander</surname><given-names>K.</given-names></name><name><surname>M&#x000e4;tt&#x000f6;</surname><given-names>J.</given-names></name><name><surname>Kassinen</surname><given-names>A.</given-names></name><name><surname>Krogius</surname><given-names>L.</given-names></name><name><surname>Saarela</surname><given-names>M.</given-names></name><name><surname>Korpela</surname><given-names>R.</given-names></name><name><surname>Palva</surname><given-names>A.</given-names></name></person-group><article-title>Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR</article-title><source>Am. J. Gastroenterol.</source><year>2005</year><volume>100</volume><fpage>373</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2005.40312.x</pub-id><pub-id pub-id-type="pmid">15667495</pub-id></element-citation></ref><ref id="B54-nutrients-11-01134"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malinen</surname><given-names>E.</given-names></name><name><surname>Krogius-Kurikka</surname><given-names>L.</given-names></name><name><surname>Lyra</surname><given-names>A.</given-names></name><name><surname>Nikkil&#x000e4;</surname><given-names>J.</given-names></name><name><surname>J&#x000e4;&#x000e4;skel&#x000e4;inen</surname><given-names>A.</given-names></name><name><surname>Rinttil&#x000e4;</surname><given-names>T.</given-names></name><name><surname>Vilpponen-Salmela</surname><given-names>T.</given-names></name><name><surname>Von Wright</surname><given-names>A.J.</given-names></name><name><surname>Palva</surname><given-names>A.</given-names></name></person-group><article-title>Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome</article-title><source>World J. Gastroenterol.</source><year>2010</year><volume>16</volume><fpage>4532</fpage><lpage>4540</lpage><pub-id pub-id-type="doi">10.3748/wjg.v16.i36.4532</pub-id><pub-id pub-id-type="pmid">20857523</pub-id></element-citation></ref><ref id="B55-nutrients-11-01134"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matto</surname><given-names>J.</given-names></name><name><surname>Maunuksela</surname><given-names>L.</given-names></name><name><surname>Kajander</surname><given-names>K.</given-names></name><name><surname>Palva</surname><given-names>A.</given-names></name><name><surname>Korpela</surname><given-names>R.</given-names></name><name><surname>Kassinen</surname><given-names>A.</given-names></name><name><surname>Saarela</surname><given-names>M.</given-names></name><name><surname>M&#x000e4;tt&#x000f6;</surname><given-names>J.</given-names></name></person-group><article-title>Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome- a longitudinal study in IBS and control subjects</article-title><source>FEMS Immunol. Med. Microbiol.</source><year>2005</year><volume>43</volume><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.femsim.2004.08.009</pub-id><pub-id pub-id-type="pmid">15747442</pub-id></element-citation></ref><ref id="B56-nutrients-11-01134"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manichanh</surname><given-names>C.</given-names></name><name><surname>Eck</surname><given-names>A.</given-names></name><name><surname>Varela</surname><given-names>E.</given-names></name><name><surname>Roca</surname><given-names>J.</given-names></name><name><surname>Clemente</surname><given-names>J.C.</given-names></name><name><surname>Gonzalez</surname><given-names>A.</given-names></name><name><surname>Knights</surname><given-names>D.</given-names></name><name><surname>Knight</surname><given-names>R.</given-names></name><name><surname>Estrella</surname><given-names>S.</given-names></name><name><surname>Hernandez</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Anal gas evacuation and colonic microbiota in patients with flatulence: Effect of diet</article-title><source>Gut</source><year>2014</year><volume>63</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2012-303013</pub-id><?supplied-pmid 23766444?><pub-id pub-id-type="pmid">23766444</pub-id></element-citation></ref><ref id="B57-nutrients-11-01134"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkes</surname><given-names>G.C.</given-names></name><name><surname>Rayment</surname><given-names>N.B.</given-names></name><name><surname>Hudspith</surname><given-names>B.N.</given-names></name><name><surname>Petrovska</surname><given-names>L.</given-names></name><name><surname>Lomer</surname><given-names>M.C.</given-names></name><name><surname>Brostoff</surname><given-names>J.</given-names></name><name><surname>Whelan</surname><given-names>K.</given-names></name><name><surname>Sanderson</surname><given-names>J.D.</given-names></name></person-group><article-title>Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome</article-title><source>Neurogastroenterol. Motil.</source><year>2012</year><volume>24</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2982.2011.01803.x</pub-id><pub-id pub-id-type="pmid">22070725</pub-id></element-citation></ref><ref id="B58-nutrients-11-01134"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalanka-Tuovinen</surname><given-names>J.</given-names></name><name><surname>Salojarvi</surname><given-names>J.</given-names></name><name><surname>Salonen</surname><given-names>A.</given-names></name><name><surname>Immonen</surname><given-names>O.</given-names></name><name><surname>Garsed</surname><given-names>K.</given-names></name><name><surname>Kelly</surname><given-names>F.M.</given-names></name><name><surname>Zaitoun</surname><given-names>A.</given-names></name><name><surname>Palva</surname><given-names>A.</given-names></name><name><surname>Spiller</surname><given-names>R.C.</given-names></name><name><surname>de Vos</surname><given-names>W.M.</given-names></name></person-group><article-title>Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome</article-title><source>Gut</source><year>2014</year><volume>63</volume><fpage>1737</fpage><lpage>1745</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2013-305994</pub-id><pub-id pub-id-type="pmid">24310267</pub-id></element-citation></ref><ref id="B59-nutrients-11-01134"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>J.</given-names></name><name><surname>Fournier</surname><given-names>C.</given-names></name><name><surname>Durdevic</surname><given-names>M.</given-names></name><name><surname>Knoblich</surname><given-names>L.</given-names></name><name><surname>Keip</surname><given-names>B.</given-names></name><name><surname>Dejaco</surname><given-names>C.</given-names></name><name><surname>Trauner</surname><given-names>M.</given-names></name><name><surname>Moser</surname><given-names>G.</given-names></name></person-group><article-title>A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome</article-title><source>Psychosom. Med.</source><year>2018</year><volume>80</volume><fpage>698</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1097/PSY.0000000000000630</pub-id><pub-id pub-id-type="pmid">30095672</pub-id></element-citation></ref><ref id="B60-nutrients-11-01134"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Lynch</surname><given-names>M.D.J.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Dang</surname><given-names>V.T.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Jury</surname><given-names>J.</given-names></name><name><surname>Umeh</surname><given-names>G.</given-names></name><name><surname>Miranda</surname><given-names>P.M.</given-names></name><name><surname>Pastor</surname><given-names>M.P.</given-names></name><name><surname>Sidani</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice</article-title><source>Sci. Transl. Med.</source><year>2017</year><volume>9</volume><fpage>eaaf6397</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aaf6397</pub-id><?supplied-pmid 28251905?><pub-id pub-id-type="pmid">28251905</pub-id></element-citation></ref><ref id="B61-nutrients-11-01134"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouzet</surname><given-names>L.</given-names></name><name><surname>Gaultier</surname><given-names>E.</given-names></name><name><surname>Del&#x02019;Homme</surname><given-names>C.</given-names></name><name><surname>Cartier</surname><given-names>C.</given-names></name><name><surname>Delmas</surname><given-names>E.</given-names></name><name><surname>Dapoigny</surname><given-names>M.</given-names></name><name><surname>Fioramonti</surname><given-names>J.</given-names></name><name><surname>Bernalier-Donadille</surname><given-names>A.</given-names></name></person-group><article-title>The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota</article-title><source>Neurogastroenterol. Motil.</source><year>2013</year><volume>25</volume><fpage>e272</fpage><lpage>e282</lpage><pub-id pub-id-type="doi">10.1111/nmo.12103</pub-id><pub-id pub-id-type="pmid">23433203</pub-id></element-citation></ref><ref id="B62-nutrients-11-01134"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdu</surname><given-names>S.</given-names></name><name><surname>Dapoigny</surname><given-names>M.</given-names></name><name><surname>Chapuy</surname><given-names>E.</given-names></name><name><surname>Artigue</surname><given-names>F.</given-names></name><name><surname>Vasson</surname><given-names>M.-P.</given-names></name><name><surname>D&#x000e9;chelotte</surname><given-names>P.</given-names></name><name><surname>Bommelaer</surname><given-names>G.</given-names></name><name><surname>Eschalier</surname><given-names>A.</given-names></name><name><surname>Ardid</surname><given-names>D.</given-names></name></person-group><article-title>Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats</article-title><source>Gastroenterology</source><year>2005</year><volume>128</volume><fpage>1996</fpage><lpage>2008</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2005.03.082</pub-id><pub-id pub-id-type="pmid">15940632</pub-id></element-citation></ref><ref id="B63-nutrients-11-01134"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohman</surname><given-names>L.</given-names></name><name><surname>Tornblom</surname><given-names>H.</given-names></name><name><surname>Simren</surname><given-names>M.</given-names></name></person-group><article-title>Crosstalk at the mucosal border: Importance of the gut microenvironment in IBS</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2015</year><volume>12</volume><fpage>36</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2014.200</pub-id><pub-id pub-id-type="pmid">25446728</pub-id></element-citation></ref><ref id="B64-nutrients-11-01134"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnsen</surname><given-names>P.H.</given-names></name><name><surname>Hilp&#x000fc;sch</surname><given-names>F.</given-names></name><name><surname>Cavanagh</surname><given-names>J.P.</given-names></name><name><surname>Leikanger</surname><given-names>I.S.</given-names></name><name><surname>Kolstad</surname><given-names>C.</given-names></name><name><surname>Valle</surname><given-names>P.C.</given-names></name><name><surname>Goll</surname><given-names>R.</given-names></name></person-group><article-title>Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: A double-blind, randomised, placebo-controlled, parallel-group, single-centre trial</article-title><source>Lancet Gastroenterol. Hepatol.</source><year>2018</year><volume>3</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(17)30338-2</pub-id><pub-id pub-id-type="pmid">29100842</pub-id></element-citation></ref><ref id="B65-nutrients-11-01134"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staudacher</surname><given-names>H.M.</given-names></name><name><surname>Lomer</surname><given-names>M.C.E.</given-names></name><name><surname>Anderson</surname><given-names>J.L.</given-names></name><name><surname>Barrett</surname><given-names>J.S.</given-names></name><name><surname>Muir</surname><given-names>J.G.</given-names></name><name><surname>Irving</surname><given-names>P.M.</given-names></name><name><surname>Whelan</surname><given-names>K.</given-names></name></person-group><article-title>Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome</article-title><source>J. Nutr.</source><year>2012</year><volume>142</volume><fpage>1510</fpage><lpage>1518</lpage><pub-id pub-id-type="doi">10.3945/jn.112.159285</pub-id><pub-id pub-id-type="pmid">22739368</pub-id></element-citation></ref><ref id="B66-nutrients-11-01134"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staudacher</surname><given-names>H.M.</given-names></name><name><surname>Lomer</surname><given-names>M.C.</given-names></name><name><surname>Farquharson</surname><given-names>F.M.</given-names></name><name><surname>Louis</surname><given-names>P.</given-names></name><name><surname>Fava</surname><given-names>F.</given-names></name><name><surname>Franciosi</surname><given-names>E.</given-names></name><name><surname>Scholz</surname><given-names>M.</given-names></name><name><surname>Tuohy</surname><given-names>K.M.</given-names></name><name><surname>Lindsay</surname><given-names>J.O.</given-names></name><name><surname>Irving</surname><given-names>P.M.</given-names></name><etal/></person-group><article-title>A Diet Low in FODMAPs Reduces Symptoms in Patients with Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial</article-title><source>Gastroenterology</source><year>2017</year><volume>153</volume><fpage>936</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2017.06.010</pub-id><pub-id pub-id-type="pmid">28625832</pub-id></element-citation></ref><ref id="B67-nutrients-11-01134"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>K.</given-names></name><name><surname>Reed</surname><given-names>D.E.</given-names></name><name><surname>Schneider</surname><given-names>T.</given-names></name><name><surname>Dang</surname><given-names>F.</given-names></name><name><surname>Keshteli</surname><given-names>A.H.</given-names></name><name><surname>De Palma</surname><given-names>G.</given-names></name><name><surname>Madsen</surname><given-names>K.</given-names></name><name><surname>Bercik</surname><given-names>P.</given-names></name><name><surname>Vanner</surname><given-names>S.</given-names></name></person-group><article-title>FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial</article-title><source>Gut</source><year>2017</year><volume>66</volume><fpage>1241</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2015-311339</pub-id><pub-id pub-id-type="pmid">26976734</pub-id></element-citation></ref><ref id="B68-nutrients-11-01134"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chumpitazi</surname><given-names>B.P.</given-names></name><name><surname>Hollister</surname><given-names>E.B.</given-names></name><name><surname>Oezguen</surname><given-names>N.</given-names></name><name><surname>Tsai</surname><given-names>C.M.</given-names></name><name><surname>McMeans</surname><given-names>A.R.</given-names></name><name><surname>A Luna</surname><given-names>R.</given-names></name><name><surname>Savidge</surname><given-names>T.C.</given-names></name><name><surname>Versalovic</surname><given-names>J.</given-names></name><name><surname>Shulman</surname><given-names>R.J.</given-names></name></person-group><article-title>Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome</article-title><source>Gut Microbes</source><year>2014</year><volume>5</volume><fpage>165</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.4161/gmic.27923</pub-id><pub-id pub-id-type="pmid">24637601</pub-id></element-citation></ref><ref id="B69-nutrients-11-01134"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huaman</surname><given-names>J.-W.</given-names></name><name><surname>Mego</surname><given-names>M.</given-names></name><name><surname>Manichanh</surname><given-names>C.</given-names></name><name><surname>Ca&#x000f1;ellas</surname><given-names>N.</given-names></name><name><surname>Ca&#x000f1;ueto</surname><given-names>D.</given-names></name><name><surname>Segurola</surname><given-names>H.</given-names></name><name><surname>Jansana</surname><given-names>M.</given-names></name><name><surname>Malagelada</surname><given-names>C.</given-names></name><name><surname>Accarino</surname><given-names>A.</given-names></name><name><surname>Vulevic</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Effects of Prebiotics vs a Diet Low in FODMAPs in Patients with Functional Gut Disorders</article-title><source>Gastroenterology</source><year>2018</year><volume>155</volume><fpage>1004</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2018.06.045</pub-id><pub-id pub-id-type="pmid">29964041</pub-id></element-citation></ref><ref id="B70-nutrients-11-01134"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halmos</surname><given-names>E.P.</given-names></name><name><surname>Christophersen</surname><given-names>C.T.</given-names></name><name><surname>Bird</surname><given-names>A.R.</given-names></name><name><surname>Shepherd</surname><given-names>S.J.</given-names></name><name><surname>Gibson</surname><given-names>P.R.</given-names></name><name><surname>Muir</surname><given-names>J.G.</given-names></name></person-group><article-title>Diets that differ in their FODMAP content alter the colonic luminal microenvironment</article-title><source>Gut</source><year>2015</year><volume>64</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2014-307264</pub-id><pub-id pub-id-type="pmid">25016597</pub-id></element-citation></ref><ref id="B71-nutrients-11-01134"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloan</surname><given-names>T.J.</given-names></name><name><surname>Jalanka</surname><given-names>J.</given-names></name><name><surname>Major</surname><given-names>G.A.D.</given-names></name><name><surname>Krishnasamy</surname><given-names>S.</given-names></name><name><surname>Pritchard</surname><given-names>S.</given-names></name><name><surname>Abdelrazig</surname><given-names>S.</given-names></name><name><surname>Korpela</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>G.</given-names></name><name><surname>Mulvenna</surname><given-names>C.</given-names></name><name><surname>Hoad</surname><given-names>C.L.</given-names></name><etal/></person-group><article-title>A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0201410</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0201410</pub-id><pub-id pub-id-type="pmid">30048547</pub-id></element-citation></ref><ref id="B72-nutrients-11-01134"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>A.C.</given-names></name><name><surname>Harris</surname><given-names>L.A.</given-names></name><name><surname>Lacy</surname><given-names>B.E.</given-names></name><name><surname>Quigley</surname><given-names>E.M.M.</given-names></name><name><surname>Moayyedi</surname><given-names>P.</given-names></name></person-group><article-title>Systematic review with meta-analysis: The efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome</article-title><source>Aliment. Pharmacol. Ther.</source><year>2018</year><volume>48</volume><fpage>1044</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1111/apt.15001</pub-id><pub-id pub-id-type="pmid">30294792</pub-id></element-citation></ref><ref id="B73-nutrients-11-01134"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Keeffe</surname><given-names>M.</given-names></name><name><surname>Lomer</surname><given-names>M.C.</given-names></name></person-group><article-title>Who should deliver the low FODMAP diet and what educational methods are optimal: A review</article-title><source>J. Gastroenterol. Hepatol.</source><year>2017</year><volume>32</volume><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/jgh.13690</pub-id><pub-id pub-id-type="pmid">28244661</pub-id></element-citation></ref><ref id="B74-nutrients-11-01134"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eswaran</surname><given-names>S.L.</given-names></name><name><surname>Chey</surname><given-names>W.D.</given-names></name><name><surname>Han-Markey</surname><given-names>T.</given-names></name><name><surname>Ball</surname><given-names>S.</given-names></name><name><surname>Jackson</surname><given-names>K.</given-names></name></person-group><article-title>A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D</article-title><source>Am. J. Gastroenterol.</source><year>2016</year><volume>111</volume><fpage>1824</fpage><lpage>1832</lpage><pub-id pub-id-type="pmid">27725652</pub-id></element-citation></ref><ref id="B75-nutrients-11-01134"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilder-Smith</surname><given-names>C.H.</given-names></name><name><surname>Materna</surname><given-names>A.</given-names></name><name><surname>Wermelinger</surname><given-names>C.</given-names></name><name><surname>Schuler</surname><given-names>J.</given-names></name></person-group><article-title>Fructose and lactose intolerance and malabsorption testing: The relationship with symptoms in functional gastrointestinal disorders</article-title><source>Aliment. Pharmacol. Ther.</source><year>2013</year><volume>37</volume><fpage>1074</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1111/apt.12306</pub-id><pub-id pub-id-type="pmid">23574302</pub-id></element-citation></ref><ref id="B76-nutrients-11-01134"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;hn</surname><given-names>L.</given-names></name><name><surname>St&#x000f6;rsrud</surname><given-names>S.</given-names></name><name><surname>Liljebo</surname><given-names>T.</given-names></name><name><surname>Collin</surname><given-names>L.</given-names></name><name><surname>Lindfors</surname><given-names>P.</given-names></name><name><surname>T&#x000f6;rnblom</surname><given-names>H.</given-names></name><name><surname>Simr&#x000e9;n</surname><given-names>M.</given-names></name></person-group><article-title>Diet low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial</article-title><source>Gastroenterology</source><year>2015</year><volume>149</volume><fpage>1399</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.07.054</pub-id><pub-id pub-id-type="pmid">26255043</pub-id></element-citation></ref><ref id="B77-nutrients-11-01134"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valeur</surname><given-names>J.</given-names></name><name><surname>Sm&#x000e5;stuen</surname><given-names>M.C.</given-names></name><name><surname>Knudsen</surname><given-names>T.</given-names></name><name><surname>Lied</surname><given-names>G.A.</given-names></name><name><surname>R&#x000f8;seth</surname><given-names>A.G.</given-names></name></person-group><article-title>Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome</article-title><source>Dig. Dis. Sci.</source><year>2018</year><volume>63</volume><fpage>429</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1007/s10620-017-4893-3</pub-id><pub-id pub-id-type="pmid">29302878</pub-id></element-citation></ref><ref id="B78-nutrients-11-01134"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cas&#x000e9;n</surname><given-names>C.</given-names></name><name><surname>Veb&#x000f8;</surname><given-names>H.C.</given-names></name><name><surname>Sekelja</surname><given-names>M.</given-names></name><name><surname>Hegge</surname><given-names>F.T.</given-names></name><name><surname>Karlsson</surname><given-names>M.K.</given-names></name><name><surname>Ciemniejewska</surname><given-names>E.</given-names></name><name><surname>Dzankovic</surname><given-names>S.</given-names></name><name><surname>Fr&#x000f8;yland</surname><given-names>C.</given-names></name><name><surname>Nestestog</surname><given-names>R.</given-names></name><name><surname>Engstrand</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Deviations in human gut microbiota: A novel diagnostic test for determining dysbiosis in patients with IBS or IBD</article-title><source>Aliment. Pharmacol. Ther.</source><year>2015</year><volume>42</volume><fpage>71</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1111/apt.13236</pub-id><pub-id pub-id-type="pmid">25973666</pub-id></element-citation></ref><ref id="B79-nutrients-11-01134"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chumpitazi</surname><given-names>B.P.</given-names></name><name><surname>Cope</surname><given-names>J.L.</given-names></name><name><surname>Hollister</surname><given-names>E.B.</given-names></name><name><surname>Tsai</surname><given-names>C.M.</given-names></name><name><surname>McMeans</surname><given-names>A.R.</given-names></name><name><surname>Luna</surname><given-names>R.A.</given-names></name><name><surname>Versalovic</surname><given-names>J.</given-names></name><name><surname>Shulman</surname><given-names>R.J.</given-names></name></person-group><article-title>Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome</article-title><source>Aliment. Pharmacol. Ther.</source><year>2015</year><volume>42</volume><fpage>418</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1111/apt.13286</pub-id><pub-id pub-id-type="pmid">26104013</pub-id></element-citation></ref><ref id="B80-nutrients-11-01134"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>R.</given-names></name><name><surname>Xia</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Nie</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Similar Fecal Microbiota Signatures in Patients with Diarrhea-Predominant Irritable Bowel Syndrome and Patients with Depression</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2016</year><volume>14</volume><fpage>1602</fpage><lpage>1611</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2016.05.033</pub-id><pub-id pub-id-type="pmid">27266978</pub-id></element-citation></ref><ref id="B81-nutrients-11-01134"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandeputte</surname><given-names>D.</given-names></name><name><surname>Falony</surname><given-names>G.</given-names></name><name><surname>Vieira-Silva</surname><given-names>S.</given-names></name><name><surname>Tito</surname><given-names>R.Y.</given-names></name><name><surname>Joossens</surname><given-names>M.</given-names></name><name><surname>Raes</surname><given-names>J.</given-names></name></person-group><article-title>Stool Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates</article-title><source>Gut</source><year>2016</year><volume>65</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2015-309618</pub-id><pub-id pub-id-type="pmid">26069274</pub-id></element-citation></ref><ref id="B82-nutrients-11-01134"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>M.</given-names></name><name><surname>Aggio</surname><given-names>R.</given-names></name><name><surname>Staudacher</surname><given-names>H.M.</given-names></name><name><surname>Lomer</surname><given-names>M.C.</given-names></name><name><surname>Lindsay</surname><given-names>J.O.</given-names></name><name><surname>Irving</surname><given-names>P.</given-names></name><name><surname>Probert</surname><given-names>C.</given-names></name><name><surname>Whelan</surname><given-names>K.</given-names></name></person-group><article-title>Volatile Organic Compounds in Feces Associate with Response to Dietary Intervention in Patients with Irritable Bowel Syndrome</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2017</year><volume>16</volume><fpage>385</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2017.09.055</pub-id><pub-id pub-id-type="pmid">28993261</pub-id></element-citation></ref><ref id="B83-nutrients-11-01134"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costea</surname><given-names>P.I.</given-names></name><name><surname>Zeller</surname><given-names>G.</given-names></name><name><surname>Sunagawa</surname><given-names>S.</given-names></name><name><surname>Pelletier</surname><given-names>E.</given-names></name><name><surname>Alberti</surname><given-names>A.</given-names></name><name><surname>Levenez</surname><given-names>F.</given-names></name><name><surname>Tramontano</surname><given-names>M.</given-names></name><name><surname>Driessen</surname><given-names>M.</given-names></name><name><surname>Hercog</surname><given-names>R.</given-names></name><name><surname>Jung</surname><given-names>F.-E.</given-names></name><etal/></person-group><article-title>Towards standards for human fecal sample processing in metagenomic studies</article-title><source>Nat. Biotechnol.</source><year>2017</year><volume>35</volume><fpage>1069</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1038/nbt.3960</pub-id><pub-id pub-id-type="pmid">28967887</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="nutrients-11-01134-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-11-01134-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of recent trials reporting on the association between baseline gut microbiota composition and association with clinical response in obesity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No. of Subjects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Condition </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dietary Intervention</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Findings</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref. </th></tr></thead><tbody><tr><td colspan="8" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Controlled trials <italic>&#x02013;</italic> weight response</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cotillard et al., 2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-randomised clinical trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49 (f = 41, m = 8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Obesity (<italic>n</italic> = 38, and <italic>n</italic> = 11 overweight)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-week energy-restricted high-protein diet followed by a 6-week weight-maintenance diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Higher gene richness (where responders were those with marked improvement of adipose tissue and systemic inflammation).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B33-nutrients-11-01134" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dao et al., 2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-randomised clinical trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49 (f = 41, m = 8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Obesity and overweight</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-week calorie restriction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Higher gene richness and <italic>Akkermansia muciniphila</italic> abundance was associated with most improved body fat distribution, fasting plasma glucose, plasma triglycerides, improvement in insulin sensitivity. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-nutrients-11-01134" ref-type="bibr">37</xref>]</td></tr><tr><td colspan="8" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Modelling studies <italic>&#x02013;</italic> weight response</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kong et al., 2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Network modelling</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 (f = 42, m = 8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Obesity and overweight</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-week energy-restricted, high-protein diet followed by maintenance phase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Baseline microbiota not identified as a predictor. Non-responders: High <italic>Lactobacillus/Leuconostoc/Pediococcus</italic>. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-nutrients-11-01134" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Korpela et al., 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Predictive modelling </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78 (f = 40, m = 38)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 cohorts with obesity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 different types of dietary interventions varying in carbohydrate quality and quantity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: High abundance of <italic>Firmicutes</italic>, where the microbiota composition was associated with change in serum cholesterol levels.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-nutrients-11-01134" ref-type="bibr">39</xref>]</td></tr><tr><td colspan="8" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Controlled trials <italic>&#x02013;</italic> glycaemic response</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kovatcheva-Datchary et al., 2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT, crossover</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39 (f = 33, m = 6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-day barley kernel-based bread</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-day white wheat flour bread</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Higher <italic>Prevotella/Bacteroides</italic> ratio and increased <italic>Dorea</italic> that could predict PPGR to barley kernel-based bread.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-nutrients-11-01134" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Korem et al., 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT, crossover</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (f = 11, m = 9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 week of 3&#x000d7; 145 g whole-grain sourdough/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 week of 3&#x000d7; 110 g refined white bread/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Specific microbial signature (especially abundances of <italic>Coprobacter fastidiosus</italic> and <italic>Lachnospiraceae bacterium</italic>) could predict PPGR to either bread. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-nutrients-11-01134" ref-type="bibr">41</xref>]</td></tr><tr><td colspan="8" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Modelling studies <italic>&#x02013;</italic> glycaemic response</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zeevi et al., 2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Machine learning algorithm </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">800 (f = 480, m = 320)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy (assessing glycaemic response)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1-week usual diet with one standardised meal with 50 g available carbohydrate/day</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Proteobacteria, Enterobacteriaceae and Actinobacteria were associated with elevated PPGRs. Non-responders: Clostridia and Prevotellaceae associated with lower PPGRs. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B6-nutrients-11-01134" ref-type="bibr">6</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mendes-Soares et al., 2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Same modelling framework as Zeevi et al., 2015 [<xref rid="B6-nutrients-11-01134" ref-type="bibr">6</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">327 (f = 255, m = 72)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy (assessing glycaemic response)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-day usual diet including four standardised meals with 50 g available carbohydrate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseline microbiota combined with other physiological characteristics was more predictive of PPGR than using only calorie or carbohydrate content of foods.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B42-nutrients-11-01134" ref-type="bibr">42</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>PPGR, postprandial glycaemic response; RCT, randomised clinical trial.</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-11-01134-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-11-01134-t002_Table 2</object-id><label>Table 2</label><caption><p>Summary of recent trials reporting on the association between baseline gut microbiota composition and association with clinical response in IBS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No. of Subjects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IBS Sub-Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dietary Intervention</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Findings</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chumpitazi et al., 2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dietary advice uncontrolled trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 children (f = 4, m = 4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paediatric Rome III; all IBS subtypes included</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low FODMAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Greater richness and diversity compared at baseline compared with non-responders. Greater abundance of <italic>Bacteroides</italic>, unclassified Ruminococcaceae and <italic>Faecalibacterium prausnitzii</italic> at baseline compared with non-responders.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-nutrients-11-01134" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Halmos et al., 2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crossover feeding RCT </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (f = 21, m = 6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rome III, all IBS subtypes included</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low FODMAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Typical Australian diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No baseline microbiota differences identified between responders and non-responders.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-nutrients-11-01134" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chumpitazi et al., 2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crossover feeding RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 children (f = 22, m = 11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paediatric Rome III; all IBS subtypes included</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low FODMAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">American childhood diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Greater abundances for a range of saccharolytic taxa including within the family Bacteroidoidaceae and order Clostridiales (e.g., <italic>F. Prausnitzii</italic>) compared with non-responders.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-nutrients-11-01134" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bennet et al., 2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dietary advice RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61 (f = 51, m = 10), 33 low FODMAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rome III; all IBS subtypes included</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low FODMAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Traditional IBS diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Increased abundance of <italic>Streptococcus</italic>, <italic>Dorea</italic> and <italic>Ruminococcus gnavus</italic> at baseline compared with non-responders. Lower dysbiosis index at baseline compared with non-responders.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B5-nutrients-11-01134" ref-type="bibr">5</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Valeur et al., 2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dietary advice uncontrolled trial </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61 (f = 54, m = 7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rome III, all IBS subtypes included</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low FODMAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Responders: Greater abundance of <italic>Bacteroides fragilis</italic>, <italic>Acinetobacter</italic>, <italic>Ruminiclostridium</italic>, <italic>Streptococcus</italic> and <italic>Eubacterium</italic> at baseline compared with non-responders. Lower abundance of <italic>Clostridia</italic>, <italic>Actinomycetales</italic>, <italic>Anaerotruncus and Escherichia</italic> at baseline compared with non-responders.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-nutrients-11-01134" ref-type="bibr">77</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>IBS, irritable bowel syndrome; RCT, randomised clinical trial.</p></fn></table-wrap-foot></table-wrap></floats-group></article>